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ZUSAMMENFASSUNG 
Pilze sind hervorragende Produzenten von Naturstoffen, die für pharmazeutische und 
agrarwirtschaftliche Anwendungen genutzt werden. Das Ziel der vorliegenden 
Doktorarbeit war es, dieses außergewöhnliche Biosynthesepotential für die Suche nach 
neuen Naturstoffen in Pilzisolaten aus dem deutschen Wattenmeer auszuschöpfen. Um 
eine effiziente und zielgerichtete Screening-Strategie zu entwickeln, wurden vier 
Kriterien zur Auswahl derjenigen Pilze herangezogen, die anschließend umfassend auf 
ihre Fähigkeiten zur Biosynthese von Naturstoffen hin untersucht wurden: (i) Pilzisolate 
von wenig erforschten Ökosystemen, (ii) weniger intensiv untersuchte Gattungen, (iii) 
genetisches Potential anhand des Sequenznachweises für Polyketidsynthase- und 
nichtribosomale Peptidsynthetase-Gene, (iv) stimulierende Effekte auf die Biosynthese 
durch die Variation von Kulturbedingungen. Die Screening-Strategie zahlte sich aus, 
denn es wurden neun neue Naturstoffe, die Calcaripeptide A–C, Calcaride A–E und ein 
Tropolon-Derivat, entdeckt. 
Die Calcaripeptide sind Cyclodepsipeptide, die von einem Calcarisporium sp. (Stamm 
KF525) isoliert wurden. Die Strukturaufklärung mit Hilfe von ein- und 
zweidimensionaler Kernspinresonanzspektroskopie wies einen ungewöhnlichen 
Makrocyclus bestehend aus zwei Aminosäuren und eine nicht-peptidische Teilstruktur 
für die Substanzen nach. Die absolute Konfiguration der Calcaripeptide wurde über 
Röntgenstrukturanalysen in Kombination mit der erweiterten Marfey-Methode 
bestimmt. Biosynthesestudien zu Calcaripeptid A zeigten, dass der nicht-peptidische 
Strukturteil von Acetat und L-Methionin stammt, was einen biosynthetischen Ursprung 
von einem Hybrid aus einer Polyketidsynthase und einer nichtribosomalen 
Peptidsynthetase nahelegt. Trotz breit angelegter Tests zum Nachweis biologischer 
Aktivitäten wiesen die Calcaripeptide keine inhibitorischen Eigenschaften auf. 
Zusätzlich produzierte der Stamm KF525 eine zweite Klasse von Naturstoffen, welche 
die neuen Calcaride A–E und fünf strukturverwandte Substanzen vom 15G256-Typ 
umfasste. Bei den Substanzen handelt es sich um lineare und makrocyclische Polyester, 
wobei die Calcaride methylierte Formen der Substanzen vom 15G256-Typ darstellen. 
Die absolute Konfiguration der Metabolite wurde über Messungen der optischen 
Rotation untersucht. Die Calcaride und Substanzen vom 15G256-Typ zeigten 
antibakterielle Aktivitäten gegenüber Staphylococcus epidermidis, Xanthomonas 
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campestris und Propionibacterium acnes, welche einer engen Struktur-Aktivitäts-
Beziehung unterlagen. 
Von einem anderen Pilzstamm, Cladosporium sp. KF501, wurden Mitglieder der 
Familie pilzlicher Tropolone isoliert. Unter den Substanzen befand sich ein neues 
Derivat, das ein Stereoisomer der bekannten Tropolone des Pilzstamms darstellt. Die 
relative Konfiguration des neuen Derivats wurde anhand einer Röntgenstrukturanalyse 
an einem Einkristall bestimmt. Die isolierten Tropolone wiesen antibakterielle und 
antifungale Eigenschaften in Testungen mit Xanthomonas campestris und Trichophyton 
rubrum auf.  
Insgesamt demonstrieren die Ergebnisse der Arbeit den hohen Wert, den Pilze aus 
marinen Habitaten für die Entdeckung neuer bioaktiver Naturstoffe besitzen. 
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SUMMARY 
Fungi are prolific producers of natural products used for pharmaceutical and agricultural 
applications. The scope of the present PhD study was to exploit this extraordinary 
biosynthetic potential for the search for new natural products from fungal isolates of the 
German Wadden Sea. In order to create a smart screening strategy, four criteria were 
applied to select fungi for subsequent thorough investigation with regard to their natural 
product biosynthetic abilities: (i) fungal isolates from a little-explored ecosystem, (ii) 
less studied genera, (iii) genetic potential according to polyketide synthase (PKS) and 
nonribosomal peptide synthetase (NRPS) gene sequences, (iv) stimulating effects on 
biosynthesis by variation of culture conditions. The screening strategy was proven 
effective as it led to the discovery of nine new natural products, namely, calcaripeptides 
A–C, calcarides A–E and one tropolone derivative.  
The calcaripeptides are cyclodepsipeptides that were isolated from a Calcarisporium sp. 
(strain KF525). The structure elucidation employing one- and two-dimensional nuclear 
magnetic resonance (NMR) spectroscopy techniques proved the compounds to possess 
an unusual macrocycle composed of two amino acids and a nonpeptidic substructure. 
The absolute configuration of the calcaripeptides was determined by X-ray 
crystallography in combination with the advanced Marfey’s method. Biosynthetic 
studies on calcaripeptide A showed that the nonpeptidic structural part of the compound 
originated from acetate and L-methionine, suggesting a biosynthetic origin from a PKS–
NRPS hybrid. Despite broad testing for biological activities, the calcaripeptides did not 
exhibit any inhibitory properties.  
In addition, strain KF525 produced a second structural class of natural products 
including the new calcarides A–E and five related compounds of the 15G256-type. The 
compounds are linear and macrocyclic polyesters with the calcarides representing 
methylated forms of the 15G256-type compounds. The absolute configuration of the 
metabolites was investigated by measurements of the optical rotation. The calcarides 
and 15G256-type compounds were found to possess antibacterial activities against 
Staphylococcus epidermidis, Xanthomonas campestris and Propionibacterium acnes 
underlying tight structure-activity relationships. 
From another fungal strain, Cladosporium sp. KF501, members of the family of 
tropolone fungal metabolites were isolated. Among the compounds was a new 
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derivative that represents a stereoisomer of the known tropolones of the strain. Single-
crystal X-ray diffraction analysis was employed in order to determine the relative 
configuration of the new derivative. The isolated tropolones showed antibacterial and 
antifungal properties when profiled against Xanthomonas campestris and Trichophyton 
rubrum. 
Overall, the results of the study demonstrate the high value of fungi from marine 
habitats for the discovery of new bioactive natural products. 
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ABBREVIATIONS 
(w/v)  weight per volume 
[α]20D  specific rotatory power; sodium D-line (589 nm); 20 °C 
[α]22D  specific rotatory power; sodium D-line (589 nm); 22 °C 
°C  degrees Celsius 
µ  absorption coefficient (in connection with X-ray crystal data) 
1D  one-dimensional 
2D  two-dimensional 
A  adenylation 
Å  ångström 
ACP  acyl carrier protein 
AT  acyl transferase 
ATP  adenosine triphosphate 
BLAST Basic Local Alignment Search Tool 
br  broad   
c  concentration 
C  condensation 
calcd  calculated 
CoA  coenzyme A 
COSY  correlation spectroscopy 
CYC  cyclase 
d  doublet 
Dcalcd  calculated density 
DEPT  distortionless enhancement by polarization transfer 
DH  dehydratase 
DMSO dimethyl sulfoxide 
DNA  deoxyribonucleic acid 
DSMZ  German collection of microorganisms and cell cultures 
Em  emission 
ER  enoyl reductase 
ESI  electrospray ionization 
ESIMS electrospray ionization mass spectrometry 
EtOAc  ethyl acetate 
EtOH  ethanol 
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Ex  excitation 
FDVA  N
α
-(2,4-dinitro-5-fluorophenyl)-D-valinamide 
g  acceleration of gravity 
g  gram 
h  hour 
HMBC heteronuclear multiple bond correlation 
HPLC  high-performance liquid chromatography 
HRESIMS high-resolution electrospray ionization mass spectrometry 
HSQC  heteronuclear single-quantum coherence 
Hz  Hertz 
IC50  half maximal inhibitory concentration 
ITS  internal transcribed spacer region 
J  spin-spin coupling constant 
K  Kelvin 
KR  ketoreductase 
KS  ketosynthase 
L  liter 
m  meter 
M  molar concentration 
m/z  mass-to-charge ratio 
MeCN  acetonitrile 
MeOH  methanol 
MHz  megahertz 
MIC  minimal inhibitory concentration 
MICs  minimal inhibitory concentrations 
min  minute 
mp  melting point 
MRSA  methicillin-resistant Staphylococcus aureus 
MS  mass spectrometry 
MT  methyl transferase 
Mult.  multiplicity 
MW  molecular weight 
NMR  nuclear magnetic resonance 
NRPS  nonribosomal peptide synthetase 
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NRPSs nonribosomal peptide synthetases 
OD600  optical density at 600 nm 
PCP  peptidyl carrier protein 
PCR  polymerase chain reaction 
Phe  phenylalanine 
PKS  polyketide synthase 
PKSs  polyketide synthases 
ppm  parts per million 
Pro  proline 
PYG  peptone yeast glucose medium 
q  quartet 
Refl.  reflections 
rpm  revolutions per minute 
s  singlet 
SAM  S-adenosylmethionine 
sh  shoulder 
SI  Supporting Information 
T  temperature 
t  triplet 
TE  thioesterase 
tR  retention time 
UV  ultraviolet 
V  unit cell volume 
WHO  World Health Organization 
Z  number of molecules per unit cell 
δ  NMR chemical shift [ppm] 
ε  molar extinction coefficient 
λmax  wavelength of maximum absorption 
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INTRODUCTION 
Fungi – an Attunement 
Every year when days get shorter and autumn comes along it is the time that fungi 
become apparent in the woods. Though edible mushrooms are often the first picture 
coming to one’s mind when thinking of fungi, there is much more fungal existence in 
our daily lives. Fungi have an impact on humans as yeasts are used for baking and 
brewage. Fungi are the main pathogens of man’s crop plants. It is to their credit that 
antibiotics were discovered, healing people on the one hand; on the other hand fungi 
cause diseases such as athlete’s foots. A closer look reveals that fungi are present on 
Earth almost everywhere, e.g., in air as spores, in soil, in ocean and fresh waters, on 
rocks, on dead organic matter or in associations with plants, animals and microbes 
including other fungi (Hawksworth and Mueller 2005, Fröhlich-Nowoisky et al. 2009). 
This diverse distribution is reflected in an estimated number of 1.5 million fungi present 
on Earth (Hawksworth 2001). 
With respect to their biological characteristics, fungi are cell wall possessing, generally 
non-motil, heterotroph organisms that represent an entire kingdom within the domain of 
the Eukaryotes. They comprise unicellular forms such as yeasts. Yet the majority of 
fungi are filamentous organisms possessing a mycelium, which is build up by filaments 
called hyphae. In addition, some species have the ability to switch between uni- and 
multicellular forms, a phenomenon referred to as dimorphism. Concerning 
reproduction, fungi show a haploid, asexual life cycle and a sexual life cycle in which a 
haploid phase alternates with a diploid phase. Characteristically, both types of 
reproduction can be observed for most species with the respective forms called 
teleomorphs (sexual reproductive state) and anamorphs (asexual reproductive state). In 
the context of metabolic activities, fungi are able to convert a broad variety of complex 
biological polymers. One outcome of their metabolic processes is the numerously 
produced, digesting exoenzymes facilitating degradation, e.g., of wood, giving fungi a 
key function as decomposers of organic material. Beside their primary metabolism, 
fungi have evolved an extraordinary rich secondary metabolism, a feature they share 
with plants and bacteria mainly (Bennett and Bentley 1989). The resulting secondary 
metabolites, often referred to as natural products, were the main study subject of the 
present PhD thesis.  
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Fungal Natural Products 
Systematic studies of fungal natural products were started in 1923 by Harold Raistrick 
and colleagues, leading to the isolation of some 200 mold metabolites such as patulin, 
penicillic acid and geodin (Raistrick 1949). Some years later when Alexander Fleming 
discovered penicillin G, a real success story of fungal natural products began (Figure 1). 
Fleming’s discovery was an observation by chance as he found an undesired 
contamination in one of his petri dishes containing a culture of staphylococci in 1928. 
He noticed that the mold, which he identified as Penicillium notatum, inhibited the 
growth of the bacteria. Fleming characterized penicillin as the mold’s active principle 
which at the same time lacked toxicity on human blood cells and animals (Fleming 
1945). It was not until ten years later that Howard W. Florey, Ernest Chain and 
colleagues were able to prepare sufficient and stable penicillin suitable for clinical trials. 
With these studies the compound was finally proved a very effective antibiotic 
(Nicolaou and Montagnon 2008). 
Stimulated by the discovery of penicillin G, a new epoch in research for biologically 
active molecules was ushered in. It turned out that especially molds and actinomycetes 
bacteria were potent natural product producers (Bérdy 2005). Further antibacterial drugs 
of fungal origin were developed, e.g., cephalosporin C identified from Cephalosporium 
acremonium (Newton and Abraham 1955) or fusidic acid, which was first isolated from 
Fusidium coccineum, and still provides high activity against resistant Staphylococcus 
strains (Godtfredsen et al. 1962, Aly et al. 2011). The more natural products from fungi 
were described, the broader the panel of applications became. Griseofulvin from 
Penicillium griseofulvum was one of the first antifungal metabolites used for therapy of 
dermatophyte infections of skin, hair and nails (Grove et al. 1952, Aly et al. 2011). 
Cyclosporin, obtained from Tolypocladium inflatum in 1971, was found to be a 
suppressor of T-cells and for the first time provided transplantation surgery with a 
selective immunosuppressive drug for administration after organ transplantations 
(Dreyfuss et al. 1976, Grabley and Thiericke 1999). The statins, e.g., lovastatin, which 
was originally isolated from Monascus ruber and later from Aspergillus terreus, 
represent another important example among fungal natural products with use in 
medicine (Alberts et al. 1980). Statins attracted attention because of their cholesterol-
lowering properties leading to the commercialization of lovastatin as an 
antihypercholesterolemic drug in 1987. Further statins followed the way to the market, 
especially semisynthetic and totally synthetic analogs derived from the fungal natural 
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statins of which the compound atorvastatin has been the leading drug of the entire 
pharmaceutical industry with respect to market share for many years (Demain and 
Sanchez 2009).   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Fungal natural products with therapeutic use in medicine. 
Regarding their basic biological features, fungal natural products in the sense of 
secondary metabolites are defined as chemical structures, which in contrast to required 
primary metabolites are not essential for the growth of the producing organism 
(Aharonowitz and Demain 1980). The set of natural products can differ from species to 
species, meaning that their production is limited to narrow taxonomic groups, 
sometimes up to the extent that compounds are species-specific (Vining 1990). 
Typically, the metabolites are produced at the end of the growth phase or in early 
stationary phase (Laatsch 2000), but exceptions can be observed. From a chemical 
perspective, natural products are characterized by low molecular weights and at the 
same time high structural complexity and diversity (Williams et al. 1989, Laatsch 
2000). One of Raistrick’s colleagues once stated about mold metabolism, “If ever there 
was a field in which a pentavalent carbon atom could turn up, this is it!” (Raphael 
Griseofulvin 
Cephalosporin C 
Fusidic acid 
Penicillin G 
Cyclosporin Lovastatin 
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1948), paraphrasing the seemingly unrestricted and partly unimaginable variety found in 
chemical structures of fungal natural products.  
On the basis of their structural diversity, the broad spectrum of biological activities of 
fungal natural products can be explained. In addition to the above mentioned 
antibacterial, antifungal, immunosuppressant and antihyperlipidemic examples, a 
plethora of further fungal compounds showing biological properties has been isolated. 
The activities range from antiviral, anti-insecticidal, antiprotozoal to antiparasitic (e.g., 
anthelmintic) effects. Furthermore, activities including cytotoxic, antitumoral, 
mutagenic, carcinogenic, teratogenic properties and different enzyme inhibitory effects 
have been assigned to fungal natural products (Keller et al. 2005). Therefore, natural 
products of fungal origin have a broad field of application not only in human medicine, 
but also in veterinary medicine and agriculture, e.g., in crop protection.  
Though the practical benefit of natural products for humans is evident, their ecological 
function and relevance in the natural environment often remains elusive. As fungi are 
sessile organisms, the production of bioactive compounds can be a chemical defense 
mechanism toward competitors rivaling for the same nutrients and habitats or as an anti-
predator adaptation (Kettering et al. 2004, Rohlfs et al. 2007). The fact that natural 
products are frequently synthesized in a specific stage of developmental processes link 
compounds and their function to the morphological differentiation of the producing 
fungi. For instance, pigments known as melanins are associated with fungal spore 
formation, contributing to the spores’ survival by the UV protecting features of 
melanins (Calvo et al. 2002). Just as well natural products are recognized as mediators 
of a number of symbiotic and parasitic interactions (Vining 1990). This relationship is 
exemplified by secondary metabolites of endophytic fungi which are correlated to the 
increased tolerance toward biotic stress in the fungi-hosting plants (Saikkonen et al. 
1998).  
For the majority of natural products, the precise ecological function has not been 
understood though. This is especially true for those compounds that have no 
demonstrated activity under laboratory conditions. The ecological role of natural 
products has therefore always been matter of a controversial debate and it has even been 
questioned whether the compounds are just the result of a “games room” of biochemical 
evolution (Zähner 1979). However, given that the biosynthesis of natural products 
involves complex enzyme systems (Laatsch 2000), which are encoded by genes 
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accounting for many kilobases of DNA (Williams et al. 1989), it is energetically a 
costly process that is logically only justified, if the compounds provide a benefit to the 
producing organism. 
Biosynthesis of Fungal Natural Products 
Despite the chemical diversity of natural products, they are produced by only a few 
biosynthetic pathways. Studies on the genes encoding fungal natural products revealed 
that they are usually clustered on a single genetic locus, a feature that was formerly 
thought to be exclusive of prokaryotic organisms (Keller and Hohn 1997). There are 
four classes of fungal natural products with regard to their chemical scaffolds which in 
turn reflect the metabolic route involved in biosynthesis: polyketides, nonribosomal 
peptides, terpenes and indole alkaloids. The basic principles of polyketide and 
nonribosomal peptide biosynthesis, being of particular interest in this study, shall be 
described more in detail here.  
Polyketides 
Polyketides are a diverse group of natural products, ranging from very simple structures 
to highly complex ones, including polyphenols, macrolides, polyenes, enediynes and 
polyethers (Hertweck 2009). The assembly of polyketides is catalyzed by large multi-
enzyme complexes called polyketide synthases (PKSs) which use short-chain 
carboxylic acids, in fungi generally acetyl coenzyme A (CoA) and malonyl CoA, as 
building blocks. During the enzymatic process, the substrates are successively 
condensed to build up carbon chains of varying length (Figure 2). A PKS contains a 
minimal set of three domains that are the catalytic units essential for chain elongation: 
The acyl transferase (AT) is responsible for the substrate recognition, the acyl carrier 
protein (ACP) functions as a transporter carrying intermediates through the catalytic 
cycle and the ketosynthase (KS) catalyzes C–C bond formations between extender units 
and the growing polyketide chain by decarboxylative Claisen reactions (Keller et al. 
2005, Crawford and Townsend 2010). The biochemistry used in PKS systems is similar 
to that in fatty acid biosynthesis known from the primary metabolism. The two 
enzymatic systems however differ in that the β-carbon of the extending chain always 
becomes fully reduced in fatty acid formation, whereas in polyketide biosynthesis β-
keto-processing reactions performed by ketoreductase (KR), dehydratase (DH) and 
enoyl reductase (ER) domains are optional. The level of reduction therefore varies 
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depending on the polyketide that is built. Additionally, the carbon chain can be 
modified by cyclase (CYC) and methyl transferase (MT) activities (Schümann and 
Hertweck 2006, Cox 2007). Despite the simple building blocks used in polyketidic 
biosynthesis, the programming of their type and number, the number of reduction 
reactions, extend of methylation, cyclization reactions as well as post-PKS steps give 
rise to very different end products. The striking diversity of polyketides is hence a result 
of the combination of these variables allowing innumerable structural possibilities 
(Keller et al. 2005, Hertweck 2009). 
 
 
 
 
 
 
 
 
 
 
Though the basic mechanisms of polyketide biosynthesis are applicable to all PKSs, 
they are divided into three major classes according to the enzyme architecture. Type I 
PKS are large multidomain enzyme systems comprising covalently fused domains that 
can either show a modular arrangement or work iteratively. In the modular type I 
system, typically found in bacteria, the catalytic domains form modules of which each is 
usually responsible for only one elongation cycle. On the contrary, in the iterative type I 
system, the domains are reused for the catalytic cycles (Hertweck 2009). The majority 
of fungal PKS are iterative type I systems and are further subdivided into non-reducing, 
partially reducing or highly reducing PKSs corresponding to the degree of reductive 
processing that takes place during the assembly (Crawford and Townsend 2010). In type 
II PKSs, the catalytic activities are present on dissociable proteins that associate to 
Figure 2. Basic mechanisms of polyketide biosynthesis (modified according to 
Crawford and Townsend 2010). KS, ketosynthase; AT, acyl transferase; ACP, acyl 
carrier protein; KR, ketoreductase; DH, dehydratase; ER enoyl reductase; enz; enzyme. 
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perform the enzymatic activities. Type II systems are exclusively found in bacteria, e.g., 
the formation of bacterial aromatic polyketides is catalyzed by type II iterative systems. 
Finally, type III PKSs are single, iteratively working KS proteins that do not require 
auxiliary enzymes and are found in plants, bacteria and fungi (Cox 2007, Crawford and 
Townsend 2010). 
Nonribosomal Peptides 
Nonribosomal peptides mainly originate from bacteria as well as fungi, comprising well 
known natural products such as cyclosporins and β-lactam antibiotics like the penicillins 
(Strieker et al. 2010). As the name suggests, the biosynthetic mechanisms of 
nonribosomal peptides differ from the ubiquitous protein formation at the ribosomes in 
primary metabolism. Unlike for ribosomal proteins, where the translation of the genetic 
code allows the biosynthesis of different proteinogenic end products at a single catalytic 
site, nonribosomal peptides are the result of product-specific enzymes called 
nonribosomal peptide synthetases (NRPSs).  
In contrast to fungal iterative PKSs, the large multifunctional NRPS enzyme systems 
have a modular organization. Each module elongates the nascent peptidyl chain by the 
addition of one specific amino acid. A typical minimal NRPS elongation module 
comprises an adenylation (A), a peptidyl carrier protein (PCP) and a condensation (C) 
domain. Analogous to the PKS biosynthesis, the A-domain selects the respective amino 
acid and activates it in form of an amino acyl adenylate (Finking and Marahiel 2004) 
(Figure 3). The spectrum of substrates for the A-domain in NRPSs is remarkably broad. 
Beside the 20 proteinogenic amino acids, also nonproteinogenic amino acids and other 
carboxylic acids, e.g., D-forms of amino acids or aryl acids, are incorporated into 
nonribosomal peptides (Fischbach and Walsh 2006). After adenylation, the activated 
amino acid is transferred to the PCP-domain, which serves as a transporter passing 
nonribosomal peptide intermediates from one catalytic center to the next. The formation 
of the C–N amide bonds between PCP-tethered amino acids and peptidyl intermediates 
of neighboring modules is finally catalyzed by the C-domain of an NRPS module 
(Finking and Marahiel 2004). At the end of NRPS biosynthesis, a termination module 
often comprises thioesterase (TE) activity and releases the nonribosomal peptide by 
either hydrolysis or macrocyclization (Finking and Marahiel 2004). Aside from the 
enzymatic domains required in NRPS modules, further tailoring reactions like N-, C- 
and O-methylation, acylation, glycosylation, heterocyclic ring formation and 
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epimerization can be conducted by optional domains integrated in the NRPSs or stand-
alone enzymes (Mootz et al. 2002). According to these biosynthetic mechanisms, the 
enormous structural diversity found among fungal nonribosomal peptides arises in the 
wide range of building blocks employed, the length of peptides as well as the various 
modifying tailoring reactions (Keller et al. 2005).  
 
 
 
 
 
 
 
 
 
 
 
Due to the modular architecture of NRPS systems, the order of elongation modules 
generally correlates with the order of amino acids incorporated (Hoffmeister and Keller 
2007). In these cases, the genes encoding a specific NRPS allow the prediction of the 
nonribosomal peptide product. However, there is increasing evidence of NRPSs for 
which this co-linearity is not true, because modules or domains are used more than once 
during peptide assembly. The NRPS for the fungal trimer enniatin, for instance, 
comprises a reduced number of modules as the three repeated structural sequences are 
catalyzed by only one set of modules in an iterative fashion (Glinski et al. 2002, Mootz 
et al. 2002). A further example for deviation from the classical NRPS systems as 
described above are a group of compounds called PKS–NRPS hybrids. In the 
biosynthetic complexes for hybrids, enzymatic activities of PKS and NRPS domains act 
together, resulting in the production of mixed peptide–polyketide compounds. The first 
Figure 3. Basic mechanisms of nonribosomal peptide 
biosynthesis (modified according to Strieker et al. 2010). A, 
adenylation; PCP, peptidyl carrier protein; C, condensation; TE, 
thioesterase; E, epimerase; aa, amino acid. 
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fungal PKS–NRPS hybrid, fusarin C, was only identified in 2004 (Song et al. 2004) and 
little is known about their biosynthetic background to date. Therefore, PKS–NRPS 
hybrids represent an interesting investigation field, probably giving rise to a highly 
diverse pool of natural products in the future. 
Need for New Natural Products 
The golden era of antibiotics from 1940 to 1980 (Demain 2013) has brought great 
benefits to humankind. With the antibiotics discovered in that time, the mortality due to 
infectious diseases was decreased significantly. Diseases formerly often lethal were now 
treatable. Microbial and plant natural products helped to almost double humans’ life 
span during the last century (Li and Vederas 2009). On the other side, having very 
effective drugs to treat infectious and other diseases at hand might have led to an 
underestimation of the constant need for the search of new drugs. The rate of discovery 
of new bioactive compounds and new drug approvals has dropped since the late 1990s 
and slowed down drastically in the 21st century (Demain 2013). One important cause 
for this decrease was the draw back by the major pharmaceutical companies from their 
natural product research facilities, in part for reasons of an unbalanced equilibrium 
between high costs required before a drug becomes approved and low market sales until 
the products become generics (Demain 2013). 
The lack of new therapeutics is dramatic as resistances against the existing drugs are 
increasing. Ever since antibiotics have been clinically applied, resistances have been 
observed. This problem is only partly manmade as microbes are faced with naturally 
occurring antibiotics in their original ecosystems, sometimes being the producers of the 
compounds themselves. The development of antibiotic resistance mechanisms therefore 
is an evolutionary consequence to guarantee their survival, no matter whether it happens 
in the ecological habitat or in a treated patient. However, the extensive administration of 
antibiotics in the therapy for humans as well as animals has resulted in the accelerated 
selection of resistant pathogenic strains (Nikaido 2009). The situation becomes even 
more problematic as genes for drug resistance can be transferred to sensitive strains.  
Today not only single-drug resistances make antibacterial treatments difficult – many 
human pathogens have evolved multidrug resistances (Levy and Marshall 2004). A 
notorious example is the methicillin-resistant Staphylococcus aureus (MRSA). Aside 
from methicillin-resistance, MRSA strains are usually resistant to aminoglycosides, 
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macrolides, tetracycline, chloramphenicol and lincosamides, too (Nikaido 2009). In 
many cases, vancomycin is the antibiotic of choice for methicillin-resistant S. aureus, 
but in the early 2000s clinical specimens with resistance to vancomycin eventually also 
emerged (Enright 2003, de Lencastre et al. 2007). MRSA strains, as other multidrug-
resistant bacteria, are often associated with hospital-acquired infections, so called 
nosocomial infections, depicting a severe problem in the national health care systems. 
In 2004, about 70% of the hospital-acquired infections in the United States were caused 
by pathogens resistant to at least one of the current antibiotics (Infectious Diseases 
Society of America 2004).  
The list of further multidrug resistant pathogens compromising effective antibiotic 
therapy is long. To name just a few: The causative organisms of tuberculosis, 
Mycobacterium tuberculosis strains, have evolved resistances toward four or more of 
the front-line treatments and even totally drug-resistant variants have emerged (Velayati 
et al. 2009, Davies and Davies 2010). As a result, tuberculosis is highly prevalent in the 
world today, leading to 1.3 million deaths in the year 2012 (Koul et al. 2011, WHO 
2013). A more recent serious threat comes from Gram-negative bacterial strains, 
notably Pseudomonas aeruginosa and Acinetobacter baumannii, which are sometimes 
resistant to all, or all but one, antibiotics (Levy and Marshall 2004). Moreover, 
resistance is also evident in microorganisms other than bacteria responsible for 
infectious diseases such as viruses, fungi or parasites (Norrby et al. 2005, Pfaller 2012).  
Aside from drug resistances, there are newly emerging pathogens for which innovative 
therapeutic approaches are required. The majority of new human infections have their 
original source in animals (Jones et al. 2008). The human immunodeficiency virus, for 
instance, is an emerging infectious agent, which found its way from the original primate 
host, the chimpanzees, to the human population (Morens and Fauci 2013). Other 
examples of newly emerging diseases include the severe acute respiratory syndrome and 
the pandemic H1N1 influenza virus, both of which have caused severe illnesses and 
deaths in the modern world (Morens and Fauci 2013). After all, infectious diseases 
remain among the leading causes of death (WHO 2013). 
The situation is equally concerning in the field of cancer treatment. Although great 
advance in cancer medicine has been made, the prognosis for a number of cancers, e.g., 
pancreatic and lung cancer, is still poor (de Bono and Ashworth 2010). An effective 
treatment is demanding due to the highly complex biology behind cancer (Luo et al. 
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2009). Moreover, as for infectious diseases, the appearance of resistance toward 
therapeutic agents represents an additional complicating component in anticancer 
therapy (Baguley 2010). It is thus estimated that in 2008 12.7 million people suffered 
from newly acquired cancer and with 13% of all deaths (7.6 million cases in 2008), 
cancer is a major cause of death worldwide (Ferlay et al. 2010, WHO 2013). 
Given that the chemical variety of current drugs seems not sufficient for today’s 
therapeutic demands in medicine, there is an urgent need for new appropriate drugs. In 
this regard, natural products play an important role in drug discovery and development 
as becomes apparent by their statistical significance in the treatment of human diseases 
(Cragg et al. 1997, Newman et al. 2003, Newman and Cragg 2007, Newman and Cragg 
2012). Despite the reduced interest of pharmaceutical companies in natural product 
research, this field still produced or was involved in approximately 50% of all small 
molecule approvals in the time from 2000 to 2010. In the area of small-molecule 
anticancer drugs, natural products or agents directly derived therefrom represent an 
important proportion (44.4%) of the drugs approved worldwide in the last 30 years. 
Similarly, drugs originating from natural products accounted for 47.1% of the approvals 
for small-molecule anti-infectives (bacterial, fungal, parasitic and viral) in the same 
time period. Among this drug class, an outstanding situation is found for antibacterial 
drugs where almost 75% of the small-molecule drugs can be traced back to a natural 
product source. These numbers illustrate that natural products are indispensable for the 
development of new drugs. Their success in human therapy obviously relies on their 
unique chemical features as compared to synthetic compounds, possessing more 
chirality centers and oxygen atoms as well as often bridged polycyclic carbon skeletons 
and therefore a higher spatial complexity than synthetic agents (Spížek et al. 2010). 
Strategies to Discover New Fungal Natural Products 
The search for new natural products is challenging, especially because re-isolation of 
known structures from natural extracts commonly occurs and the supply of compound is 
often a limiting factor. For this reason, good screening strategies are essential for the 
successful isolation and characterization of new compounds.  
The producing organism certainly plays a crucial role for natural product discovery. 
With regard to supply of sufficient compound, microbial sources such as bacteria and 
fungi have moved into the focus of natural product research, since they can be 
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fermented in large scales in the laboratory, yielding good quantities of compounds 
without harming the natural environment. While mainly terrestrial fungi and bacteria, 
e.g., from soil, have been of interest for natural product discovery for a long time, a 
great fraction of the world’s microbial diversity remains to be explored (Harvey 2008, 
Bérdy 2012). One strategy for the search of new natural products is hence the 
investigation of microbes from little-explored environments. Marine habitats, for 
instance, harbor a largely untouched number of microbes and those studied turned out to 
be prolific producer of new bioactive compounds (Bhatnagar and Kim 2010, Imhoff et 
al. 2011). The same is true for endophytic microorganisms and in particular endophytes 
from rainforests represent a huge, unexplored source for natural products (Strobel et al. 
2004, Bérdy 2012). In addition, only few taxonomic groups have been examined 
thoroughly with regard to their bioactive metabolites production. In the case of fungi, 
these are especially Penicillium, Aspergillus or Fusarium isolates, whereas many other 
species have been less intensively studied and certainly bear an untapped potential for 
the production of yet unknown compounds (Bérdy 2005, Dictionary of Natural Products 
2012).  
For cultivation of microorganisms, a stimulation of natural product biosynthesis by 
systematically changing the culture conditions has been approved as an effective 
screening strategy. The parameters can be easily accessible ones including media 
composition, aeration, pH value, temperature or shape of culture vessels (Bode et al. 
2002). The method has not only shown differences in quantities of metabolites 
produced, but also induced the production of many different natural products from a 
single strain. For example, the cultivation of Aspergillus ochraceus in different culture 
flasks and the variation of agitation during cultivation (e.g., still cultures, shaken 
cultures, Penicillium flasks, different fermenters) resulted in the formation of 15 
additional compounds which were formerly unknown from the strain (Fuchser 1996). 
Intensive studies on the influence of several culture conditions on microbial metabolism 
enabled Zeeck and his colleagues to isolate more than 100 natural products belonging to 
25 structural classes from just six microorganisms (Bode et al. 2002). Relating to the 
variation of culture media, an addition of epigenetic modifiers has recently gained 
increasing attention. Epigenetic modifiers regulate the level of e.g. acetylation and 
methylation in histones and thereby control the transcriptional accessibility of 
biosynthetic gene clusters of natural products. The use of culture media treated with 
epigenetic modifying agents can hence result in a significant change of metabolic 
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profiles including the production of unknown compounds as has been shown for 
Cladosporium cladosporioides (Williams et al. 2008).  
Another special culture set-up are co-cultivation experiments by incubation of fungal 
strains with other species. Reflecting the role of natural products as signaling molecules 
in the interaction within a species or among different species, co-cultivations can trigger 
the activation of specific metabolic pathways. Cueto et al. (2001) applied this approach 
by employing a mixed fermentation of a Pestalotia strain together with a marine 
bacterium and thereby discovered the new antibacterial compound pestalone. 
Remarkably, the interplay of the two organisms was essential for pestalone biosynthesis 
as no production was observed in cultivations of either strain alone.  
The aforementioned strategies applied in natural product research are culture-dependent. 
However, less than 5% of known fungi can be cultured in the laboratory (Bérdy 2012). 
In this regard, the growing genetic data pool nowadays allows natural product chemists 
to broaden the screening strategies widely by genome mining including culture-
independent techniques. The identification of conserved regions in biosynthetic genes, 
e.g., PKS and NRPS genes, by polymerase chain reaction (PCR) experiments provides 
information if an organism has the putative genetic equipment for the formation of 
natural products. This information is a helpful tool for the decision on whether or not a 
strain is worth a detailed investigation. In addition, the increasing number of genome 
sequences from fungi provides insights into the number of biosynthetic gene clusters 
present in fungal strains. Impressively, the genomic sequence data of several fungal 
strains proved that the vast majority of biosynthetic gene clusters remains silent under 
standard fermentation conditions. For instance, Aspergillus nidulans harbors 
biosynthetic genes for 27 polyketides, 14 nonribosomal peptides, one terpene and two 
indole alkaloids, though considerably less metabolites have been ascribed to the strain 
even after extensive screening campaigns (Bok et al. 2006). These numbers by far 
exceeded anticipated expectations for natural product gene clusters in a single strain and 
promise the discovery of numerous new natural products by molecular tools in the 
future. Therefore, several possible ways to gain access to the usually silent gene clusters 
exist.  
One feasible approach comprises the activation of silent genes by incorporation and 
expression of the entire biosynthetic gene cluster in an appropriate heterologous host. 
Ishiuchi et al. recently cloned five PKS and one NRPS genes from various fungal 
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species into a yeast expression vector. The subsequent plasmid-based expression in an 
engineered Saccharomyces cerevisiae strain allowed the identification of six 
polyketides and two nonribosomal peptides, among them the so far undescribed 7-
hydroxy-fumiquinazoline F (Ishiuchi et al. 2012). Though further development of the 
techniques is needed, heterologous expression offers an enormous potential for natural 
product discovery, in particular for so far uncultured microorganisms from 
environmental samples. 
Alternatively, the biosynthesis of cryptic natural products can be triggered by 
manipulating regulatory factors of the silent gene clusters. Many biosynthetic gene 
clusters comprise pleiotropic regulators which can positively or negatively affect gene 
transcription. By means of overexpression or deletion of the transcriptional factors, the 
biosynthetic pathways may be switched on (Brakhage and Schroeckh 2011). Lae A, as a 
good example, is a global regulator of secondary metabolism in Aspergillus species. A 
deletion of laeA blocks the expression of gene clusters for sterigmatocystin and 
penicillin in A. nidulans (Bok and Keller 2004). In contrast, overexpression of laeA 
enhances gene expression for a variety of natural products including the antitumor 
compound terrequinone A, which was previously unknown from this Aspergillus 
species (Bok et al. 2006). In other cases, transcription factors are pathway-specific and 
sometimes control the expression of all genes in a certain biosynthetic cluster 
(Scherlach and Hertweck 2009). As a consequence, the overexpression of the pathway-
specific regulator genes can lead to an expression of otherwise silent gene clusters. As 
proof of principle, Bergmann et al. (2007) activated a PKS–NRPS hybrid gene in A. 
nidulans through overexpression of the respective activator gene (apdR) and thereby 
isolated the new PKS–NRPS hybrids aspyridones A and B. Similarly, the exchange of 
promoters of biosynthetic genes is a possible strategy for natural product discovery. 
Chiang et al. (2009) replaced the native promoter of a transcription activator in a PKS 
gene cluster of A. nidulans with an inducible promoter. By use of this technique, the 
group induced the production of the novel polyketide asperfuranone, proving the 
approach successful.  
As generally true, the different screening strategies for natural product discovery all 
have their advantages and drawbacks. The access to little-explored habitats can be 
restricted, cultivation of rare microbes is often labor- and time-intensive, genome 
mining approaches are cumbersome and have so far mainly been performed with only a 
INTRODUCTION                                                                                                                                                                       22 
few model organisms such as Aspergillus species. Thus, the identification of the entire 
plethora of fungal natural products presumably requires the whole spectrum of possible 
approaches, further developments of new techniques as well as combinations of the 
different strategies. 
Scope of the Thesis  
In the present PhD thesis 109 fungal isolates from the German Wadden Sea were 
investigated with regard to their natural product biosynthesis. The main scope of the 
thesis was to identify new and preferably bioactive natural products. In order to achieve 
this aim, several culture-dependent and molecular approaches approved for natural 
product discovery were combined, creating a smart overall screening strategy that 
allowed a comprehensive analysis of the metabolic potential of the fungi.  
In detail, the criteria by which fungal isolates were selected for the search of new 
natural products comprised 
 fungal isolates from a little-explored ecosystem 
 less studied genera  
 genetic potential according to PKS and NRPS gene sequences 
 stimulating effects on biosynthesis by variation of culture conditions. 
Fungal Isolates from a Little-Explored Ecosystem 
The fungal isolates originated from water samples of the German Wadden Sea. The 
Wadden Sea not only represents a barely investigated environment concerning fungi, 
but also is a unique and highly dynamic ecosystem which is characterized by the 
variability of physical and chemical parameters based on seasonal and tidal changes 
(Liebezeit et al. 1994, Grunwald et al. 2007). As the adaptation of fungi to such an 
extraordinary environment requires special metabolic abilities, it was assumed that this 
might also apply for the fungi’s natural product biosynthetic capabilities.  
Less Studied Genera 
The fungal isolates in the study comprised species mainly belonging to ascomycetes as 
well as some basidiomycetes and zygomycetes. Almost a third of the isolates (30 
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strains) were affiliated to the genus Penicillium. Though Penicillia are prolific 
producers of bioactive compounds, it is also one of the best investigated fungal genera 
regarding natural products and therefore the probability to find already characterized 
compounds is high. To avoid a re-isolation of known natural products, the focus of the 
screening was set to other, less examined genera or isolates that did not show high 
similarities to gene sequences deposited at GenBank, being putative new species. 
Genetic Potential According to PKS and NRPS Gene Sequences 
The fungi’s genetic potential to produce polyketides or nonribosomal peptides was 
investigated by PCR amplification of the respective biosynthetic gene fragments and 
subsequent sequencing. For PKS genes, degenerative primer pairs (LC1 and LC2c, LC3 
and LC5c) for the amplification of the KS-domain were used (Bingle et al. 1999). The 
primers for NRPS genes amplified fragments of the C-domain (Klotz 2010). On the 
basis of the PCR and sequencing data, only PKS- and NRPS-positive strains were 
selected for further investigations of chemical profiles. 
Stimulating Effects on Biosynthesis by Variation of Culture Conditions 
All 109 isolates were screened for their natural product formation in one standard 
culture condition (modified Wickerham medium, still cultures for filamentous fungi and 
shaken cultures for yeasts). In order to induce the activation of gene clusters that were 
silent under the standard fermentation condition, a selection (29 strains) of less studied 
genera and PKS-/NRPS-positive isolates was cultured in five different conditions, more 
precisely, four different media (potato-carrot medium, modified malt extract medium, 
Czapek medium, casamino acids glucose medium) and shaking conditions in modified 
Wickerham medium (except for the yeasts of the selection). 
The general methodologies employed for the analysis and dereplication of natural 
products in the extracts from fungal cultures included HPLC, MS and bioactivity 
screenings. Putative new bioactive compounds were purified by chromatographic means 
and elucidated in structure on the basis of NMR spectra. The identification of new 
natural products raised further questions concerning their stereochemistry, bioactivities 
and biosynthesis which were subsequently investigated. 
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Abstract 
The isolation and structure elucidation of the novel calcaripeptides A (1), B (2), and C 
(3) and studies on their biosynthetic origin are described. The calcaripeptides were 
identified from Calcarisporium sp. strain KF525, which was isolated from the German 
Wadden Sea. Compounds 1−3 are macrocyclic structures composed of a proline and a 
phenylalanine residue as well as a nonpeptidic substructure. Structure elucidation was 
achieved by applying one- and two-dimensional NMR spectroscopy supported by high-
resolution mass spectrometry. X-ray crystallography was performed to determine the 
relative configuration of 1. The absolute configuration of 1 was assigned by HPLC of 
the amino acids after hydrolysis of the molecule and derivatization with chiral agents. 
Studies on the biosynthesis by feeding 
13
C-labeled substrates revealed that the 
nonpeptidic part of 1 originates from acetate and L-methionine. The involvement of a 
hybrid between a polyketide synthase and a nonribosomal peptide synthetase in the 
biosynthesis of the calcaripeptides is discussed. 
Introduction 
With the aim to discover new natural products, fungal strains from the German Wadden 
Sea were analyzed regarding their metabolite profiles. In Wadden Sea habitats often 
both true marine organisms and organisms from terrestrial and freshwater habitats 
frequently occur together. The Calcarisporium sp. strain KF525 attracted attention 
because it produced a set of metabolites that could not be identified by extensive 
searches of the literature and databases. Fungi of the genus Calcarisporium show a 
widespread occurrence on wood (Sutton 1973, Cooper 2005) and leaf litter (Rambelli et 
al. 2004, Somrithipol and Jones 2006), in plants as endophytic fungi (Gong and Guo 
2010, Ji et al. 2004), or in coal spoil tips (Evans 1971). Commonly, Calcarisporium 
spp. are found as mycoparasites or symbionts of higher basidiomycetes and 
ascomycetes (Sutton 1973, Barnett 1958, Barnett and Lilly 1958, Watson 1955, Carrión 
and Rico-Gray 2002, Rombach and Roberts 1987). For some mycoparasitic strains of 
Calcarisporium sp., the ability to reduce feed spoiling molds or fungal plant pathogens, 
like those responsible for mildews, was observed. Hence, the use of Calcarisporium 
culture filtrates as feed-protecting preservatives and as biocontrol agents in crop 
protection has been discussed (Ji et al. 2004, Carrión and Rico-Gray 2002, Hijwegen 
1989, Hijwegen and Verhaar 1993). It is well known that predatory interactions of 
microbes are often mediated by enzymes or small-molecule compounds and toxins. 
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Even though this has also been assumed to be the case for the antifungal interplay of 
Calcarisporium species (Hijwegen 1989), few natural products have been described for 
the genus (Dictionary of Natural Products 2012). Among them are antifungal 
compounds such as 15-azahomosterols (Chrisp et al. 1990), aurovertins inhibiting 
mitochondrial ATP synthesis and ATPases (Baldwin et al. 1964, Mulheirn et al. 1974, 
Osselton et al. 1974), and calcarisporins B1−B4, with calcarisporin B1 showing 
cytotoxic activity (Yu et al. 2002a, Yu et al. 2002b). 
The marine-derived isolate KF525 of Calcarisporium sp. was shown to produce a 
metabolite spectrum different from those of other known Calcarisporium strains. The 
isolation of these metabolites from the fungal mycelium yielded the novel, structurally 
related calcaripeptides A (1), B (2), and C (3) described here (Figure I.1). Analysis of 
the NMR spectroscopic data showed the compounds to be macrocyclic structures 
consisting of two amino acids (proline and phenylalanine) and a nonpeptidic 
substructure. The nonpeptidic chain varies in structure between the three compounds. 
The absolute configuration of 1 was determined by X-ray crystallography in 
combination with the configuration data of the amino acids obtained by HPLC analysis 
after hydrolysis of the molecule and chemical derivatization. The biosynthesis of 1 was 
investigated by feeding 
13
C-labeled precursors.   
Results and Discussion 
Strain KF525 was identified as a Calcarisporium sp. based on morphological 
characteristics, in particular microscopic examination of the conidia and conidiophores, 
and on sequence analysis of the internal transcribed spacer region. As the variation of 
culture conditions can often be reflected in altered metabolite patterns, the influence of 
four different culture media as well as static and shaking cultivation conditions on the 
metabolite production of KF525 was tested. As a response to these varied culture 
conditions, the strain produced diverse metabolite profiles. While known compounds of 
the genus Calcarisporium were not found, new metabolite spectra were identified. An 
extract obtained from the mycelia of KF525 grown in modified casamino acids glucose 
medium (Stevens 1974) under shaking conditions was fractionated by preparative 
HPLC, yielding compounds 1−3. 
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High-resolution ESIMS measurements along with the spectroscopic data gave a 
molecular formula of C27H36N2O5 for 1, requiring 11 degrees of unsaturation. The 
structure of 1 was established on the basis of one- and two-dimensional NMR spectra 
(
1
H, 
13
C (
1
H decoupled and DEPT), COSY, HSQC, and HMBC; see Table I.1). The 
13
C 
NMR spectrum showed particularly intense signals at δC 129.8 and 130.7 accounting for 
two magnetically equivalent carbons each (C-6″ + C-8″ and C- 5″ + C-9″). These 
aromatic carbons together with the further aromatic methine signal of C-7″ (δC 128.3) 
and the quaternary carbon C-4″ (δC 137.4) gave evidence of a monosubstituted benzene. 
Four carbonyl functions, C-3 (δC 198.6), C-1 (δC 174.2), C-1′ (δC 171.2), and C-1″ (δC 
171.8), were observed, of which the latter three had chemical shifts characteristic of 
amide and ester carbonyl groups. Additionally, the 
13
C NMR spectrum revealed the 
presence of two olefinic carbons, C-4 (δC 136.6) and C-5 (δC 149.6), four methyl 
groups, six methylene carbons, and five methine carbons. 
4 
1 
2 
3 
1 
2 
3 
5 
6 
7 
8 9 1' 2' 
3' 
4' 
5' 
1" 
2" 
3" 
4" 
5" 9" 
6" 8" 
7" 
Figure I.1. Structures of calcaripeptides A–C (1–3), 
isolated from Calcarisporium sp. KF525. 
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Table I.1. 
1
H (600 MHz) and 
13
C (150 MHz) NMR spectroscopic data of calcaripeptide 
A (1) in methanol-d4. 
Position δC, Type δH, Mult. (J in Hz) COSY HMBC NOESY
a 
1 174.2, C         
2   49.7, CH 4.23, q (6.9) 2-CH3 1, 3, 4, 5, 2-CH3, 
2'' 
5, 2-CH3 
3 198.6, C     
4 136.6, C     
5 149.6, CH 6.42, br d (10.4) 6, 4-CH3 3, 4, 6, 7, 4-CH3, 
6-CH3 
2, 6, 7a/8a, 7b,      
4-CH3, 6-CH3, 2'' 
6   35.2, CH 2.54, m 5, 7b, 6-CH3 4, 5, 7, 6-CH3 5, 7a/8a, 8b, 4-CH3, 
6-CH3 
7a   35.7, CH2 1.40, m
b 
 5, 6, 8, 6-CH3 5, 6, 7b, 9, 6-CH3, 
2''  
7b  1.06, m 6, 8a, 8b 5, 8, 9 5, 7a/8a, 9, 2'' 
8a   35.9, CH2 1.40, m
b 
7b, 8b, 9 6, 7, 9 5, 6, 7b, 9, 6-CH3, 
2''  
8b  1.32, m 7b, 8a, 9 5, 7, 9, 9-CH3 6, 9 
9   75.0, CH 4.65, m 8a, 8b, 9-CH3 7, 9-CH3, 1' 7a/8a, 7b, 8b,        
9-CH3 
2-CH3   14.3, CH3 1.28, d (6.9) 2 1, 2, 3  2, 5'' + 9'', 6'' + 8'' 
4-CH3   12.2, CH3 1.73, d (1.2) 5 3, 4, 5, 6, 7,       
6-CH3 
5, 6 
6-CH3   20.7, CH3 1.01, d (6.6) 6 5, 6, 7, 8 5, 6, 7a/8a 
9-CH3   21.0, CH3 1.20, d (6.2) 9 8, 9 9, 2'' 
1' 171.2, C     
2'   60.5, CH 3.92, br d (7.0) 3b' 1', 3', 4', 5' 3a', 3b', 5a', 2'', 3a'', 
3b'', 5'' + 9'' 
3a'   28.8, CH2 2.06, br dd (12.3, 7.0) 3b', 4' 1', 2', 4', 5' 2', 3b', 4' 
3b'  1.13, m 2', 3a', 4' 1', 2', 4', 5' 2', 3a', 4', 5a', 5'' + 
9'', 6'' + 8'', 7'' 
4'   22.7, CH2 1.79, m 3a', 3b', 5a', 
5b' 
2', 3', 5' 3a', 3b', 5a', 5b' 
5a'   46.8, CH2 3.43, dt (11.8, 8.8) 4', 5b' 2', 3', 4', 1'' 2', 3b', 4', 5'' + 9'' 
5b'  3.36, ddd (12.2, 9.2, 
3.2) 
4', 5a' 2', 3', 4', 1'' 4' 
1'' 171.8, C     
2''   53.8, CH 5.27, dd (9.1, 5.6) 3a'', 3b'' 1, 1'', 3'', 4'' 5, 7a/8a, 7b, 9-CH3, 
2', 3a'', 3b'', 5'' + 9'' 
3a''   41.4, CH2 3.04, dd (12.9, 5.6) 2'', 3b'' 1'', 2'', 4'', 5'' + 9'' 2', 2'', 3b'', 5'' + 9'' 
3b''  2.86, dd (12.9, 9.1) 2'', 3a'' 1'', 2'', 4'', 5'' + 9'' 2', 2'', 3a'', 5'' + 9'' 
4'' 137.4, C     
5'' + 9'' 130.7, CH 7.22, br d (8.4) 6'' + 8'' 2'', 3'', 7'', 5'' + 9'' 2-CH3, 2', 3b', 5a', 
2'', 3a'', 3b'' 
6'' + 8'' 129.8, CH 7.31, br dd (8.4, 7.3) 5'' + 9'', 7'' 4'', 6'' + 8'' 2-CH3, 3b' 
7'' 128.3, CH 7.25, br t (7.3) 6'' + 8'' 5'' + 9'' 3b' 
a
The NOESY NMR spectrum was recorded at 500 MHz. 
b
Proton signals of 7a and 8a overlap. 
The 
1
H NMR spectrum showed five aromatic protons (Table I.1), corroborating the 
monosubstituted benzene already deduced from the 
13
C NMR spectrum. HMBC 
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correlations of H2-3″ (δH 2.86 and 3.04) to the aromatic carbons (C-4″, C- 5″ + C-9″) as 
well as to C-2″ and C-1″ established a phenylalanine residue as a partial structure of 1. 
The COSY spectrum displayed couplings between H2-3′ (δH 1.13 and 2.06), H2-4′ (δH 
1.79), and H2-5′ (δH 3.36 and 3.43) indicating three consecutive methylene groups, 
characteristic of a proline residue. In addition, correlations of H-2′ (δH 3.92) to H-3b′ in 
the COSY spectrum and to C-1′ in the HMBC spectrum evidenced that C-2′ was the 
proline α-carbon. The amide linkage between the phenylalanine and proline residues 
was proven by an HMBC correlation of H2-5′ to C-1″ and is consistent with the 
chemical shift of C-1″ (δC 171.8). A coupling of H-9 to C-1′ indicated a connection 
between CH-9 and C-1′, which was further characterized as an ester bond by the 
respective chemical shifts (δC 75.0, δH 4.65, and δC 171.2). The COSY spectrum 
revealed that H-9 was part of a proton spin system that reached from 9-CH3 (δH 1.20) to 
H-5 (δH 6.42) including the methyl group 6-CH3. According to the chemical shifts, CH-
5 (δC 149.6, δH 6.42) was olefinic. The methyl-substituted, olefinic carbon C-4 had to be 
located adjacent to CH-5 due to long-range H,C-couplings of H-5 to C-4 and 4-CH3 and 
of 4-CH3 (δH 1.73) to C-4 and C-5. The E-configuration of the double bond was 
determined on the basis of the NOESY spectrum, in which 4-CH3 showed a more 
intense cross-peak with H-6 than with H-5. In addition, the configuration was supported 
by a NOESY cross-peak between 6-CH3 and H-5. HMBC correlations of H-2 (δH 4.23) 
to 2-CH3, C-1, and C-3 as well as correlations of H-5 and 4-CH3 to C-3 completed the 
consecutive chain from C-1 to C-9. Finally, correlations of H-2 to C-2″ and H-2″ to C-1 
linked C-1 to the phenylalanine residue via an amide bond.  
The aromatic ring, the proline ring, the macrocycle, four carbonyl groups, and the 
double bond Δ4,5 accounted for 11 degrees of unsaturation, as was required by the 
molecular formula of 1. Thus, a cyclodepsipeptide structure was established for 1. 
A single-crystal X-ray diffraction analysis of a sample recrystallized from MeOH 
confirmed the structure of 1 and established its relative configuration. It was observed 
that the asymmetric unit of 1 consists of five different crystallographically distinct 
molecules with identical relative configuration. Small differences are found only in the 
conformation of each molecule. Figure I.2 shows one of these molecules as a 
representative. The absolute configuration of 1 was then deduced from the 
configurations of the phenylalanine and proline residues. Their configurations were 
assigned by HPLC analyses of their D-FDVA (N
α
-(2,4-dinitro-5-fluorophenyl)-D-
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valinamide) derivatives (advanced Marfey’s method) after hydrolysis of the molecule. 
As comparative standards, commercially available L-amino acids were derivatized with 
D-FDVA and L-FDVA. By comparison of the sample and standards, both the 
phenylalanine and the proline residue were proven to be L-configured. Combining this 
information with that of the X-ray analysis, the absolute configurations at all 
stereogenic centers of 1 were determined as follows: 2S, 6R, 9R, 2′S, and 2″S; the 
conformation of the proline amide bond was cis.  
 
 
 
 
 
 
 
 
The NMR spectra of 2 were very similar to those of 1 (Table I.2). Because the spectra 
of 2 were recorded in the aprotic solvent acetone-d6 instead of methanol-d4, an 
additional signal at δH 7.51 appeared in the 
1
H NMR spectrum of 2 corresponding to the 
amide proton NH-2″. Couplings between NH-2″ and CH-2″ in the COSY spectrum 
confirmed their vicinity, as was already deduced from the spectroscopic data of 1. 
Furthermore, the NMR spectra of 2 lacked the signal of the methyl group at C-2, which 
was fully consistent with a mass difference of 14 between structures 1 and 2. In 
accordance with the loss of the methyl group, CH2-2 was a methylene group. The 
signals of H-2a and H-2b (δH 4.32 and 3.15) showed low intensities, and the carbon 
signal of C-2 (δC 48.2) was weak. Therefore, its chemical shift had to be deduced from 
the HSQC spectrum. The low signal intensities can be ascribed to the acidic nature of 
CH2-2 being in the α-position of a β-ketoamide function. The absolute configuration of 
2 was postulated in analogy with 1, yet it was not empirically confirmed.  
The NMR spectra of 3 proved that its structure was almost identical to 1, except for the 
lack of the methyl-substituted double bond (Table I.2). This was in agreement with a 
Figure I.2. Molecular structure of one of the 
five crystallographically distinct molecules in 
the crystal structure of 1. 
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mass decrease of 40 compared to 1, accounting for C3H4. The structure of 3 was 
confirmed by the analysis of the two-dimensional NMR spectra. The absolute 
configuration of 3 was also postulated in analogy with 1. 
Table I.2. 
1
H and 
13
C NMR spectroscopic data of calcaripeptide B (2) (500 MHz and 
125 MHz) and calcaripeptide C (3) (600 MHz and 150 MHz) in acetone-d6. 
   Calcaripeptide B (2)  Calcaripeptide C (3) 
Position  δC, Type δH, Mult. (J in Hz)  δC, Type δH, Mult. (J in Hz) 
1   167.5, C     171.0, C   
2a    48.2, CH2
a
 4.32, br s    52.3, CH 3.66, q (6.9) 
2b   3.15, br s    
3  196.3, C   209.3, C  
4  136.0, C     44.1, CH 2.85, m 
5a  149.4, CH 6.40, br d (10.1)    31.8, CH2 1.53, m
b
 
5b      1.06, m 
6a    34.6, CH 2.53, m    35.3, CH2 1.67, m 
6b      1.53, m
b
 
7a    35.4, CH2 1.44, m
b
    74.0, CH 4.84, m 
7b   1.15, m    
8a    35.6, CH2 1.48, m
b
    
8b   1.32, m    
9    74.1, CH 4.63, m    
2-CH3       14.5, CH3 1.22, d (6.9) 
4-CH3    11.6, CH3 1.70, d (1.3)    15.6, CH3 1.02, d (6.7) 
6-CH3    20.6, CH3 0.98, d (6.6)    
7-CH3       21.0, CH3 1.19, d (6.3) 
9-CH3    20.9, CH3 1.18, d (6.2)    
1'  171.2, C   172.2, C  
2'    59.7, CH 3.85, br d (7.5)    59.8, CH 3.90, m 
3a'    29.0, CH2 2.01
c
    30.3, CH2 1.87, m 
3b'   1.29, m   1.46, m 
4a'    22.5, CH2 1.77, m    22.4, CH2 1.88, m 
4b'      1.71, m 
5a'    46.2, CH2 3.39, m    46.3, CH2 3.38, m 
5b'   3.34, m    
1''  170.6, C   169.6, C  
2''    53.4, CH 5.18, m    54.2, CH 4.97, m 
3a''    41.2, CH2 3.08, dd (12.8, 5.0)    40.6, CH2 3.06, ddt (12.5, 4.7, 2.5) 
3b''   2.80, dd (12.8, 9.0)   2.93, dddd (12.5, 10.0, 3.2, 2.1) 
4''  137.7, C   138.2, C  
5'' + 9''  130.3, CH 7.20, br d (8.4)  130.2, CH 7.25, br d (7.5) 
6'' + 8''  129.3, CH 7.31, br dd (8.4, 7.4)  129.2, CH 7.30, br t (7.5) 
7''  127.7, CH 7.24, br t (7.4)  127.5, CH 7.23, br t (7.5) 
NH-2''     7.51, br d (6.7)     7.61, br d (7.5) 
a
Signal deduced from the HSQC spectrum. 
b
Proton signals of overlap. 
c
Signal partially obscured. 
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Structurally, the calcaripeptides are related to acremolides A and B (Ratnayake et al. 
2008). The compounds share the feature of being cyclodepsipeptides containing an L-
proline-L-phenylalanine moiety that together with a nonpeptidic partial structure forms 
the macrocycle. However, the nonpeptidic part of the acremolides and calcaripeptides 
differs, and the acremolides possess an additional seven-membered alkyl side chain 
connected to the ring. The 16- and 14-membered rings of 1, 2, and 3 are unusual for 
natural products. 
The calcaripeptides were tested for activities against five bacterial test strains, three 
fungal test strains, one oomycete, and two cell lines as well as for inhibition of selected 
enzyme targets (glycogen synthase kinase-3β, acetylcholinesterase, phosphodiesterase 
4B2, and protein tyrosine phosphatase 1B). In addition, 1 was tested in further assays 
including 24 cell lines. Despite the broad panel of 43 assays, neither antibacterial, 
antifungal, and cytotoxic properties nor inhibition of the enzyme targets could be 
detected for the calcaripeptides (data not shown; for information on test strains, cell 
lines and enzymes see the Supporting Information (SI)). 
Judging from the structure, a polyketidic biosynthetic origin of the nonpeptide 
substructure of the calcaripeptides was assumed. Polyketides are a structurally diverse 
class of natural products synthesized by polyketide synthases (PKS). The substrates of 
PKS enzymes are CoA thioesters of small carboxylic acids, such as acetate and 
malonate. In order to prove the suggested biosynthetic pathway of 1, feeding 
experiments using 
13
C-labeled precursors were carried out. The feeding experiment with 
1-
13
C-acetate led to an enrichment of the 
13
C signals in the positions 1, 3, 5, 7, and 9 
(Figure I.3). Therefore, the chain that connects the carboxy group of the L-proline 
residue with the amino group of the L-phenylalanine residue is built up by five acetate 
units with the biosynthesis beginning at 9-CH3 and progressing toward C-1. In addition, 
a slight enhancement of the 
13
C NMR signal intensities for C-1′ and C-5′ was observed, 
revealing two acetate building blocks for the L-proline moiety. The incorporation of 
13
C-labeled acetate into the L-proline substructure shows that a portion of the amino 
acid was synthesized de novo, and the labeling pattern is consistent with its formation 
from α-ketoglutarate. The methyl groups of 1, 2-CH3, 4-CH3, and 6-CH3, originate from 
S-adenosylmethionine (SAM), as was confirmed by the enhancement of their 
13
C NMR 
signals after feeding L-methionine-methyl-
13
C (Figure I.3). 
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Figure I.3. Biosynthetic origin of calcaripeptide 
A (1) as determined by 
13
C-labeling. For 
detailed information on the calculation of the 
13
C enrichment see SI. 
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According to the feeding studies, a polyketidic origin of the nonpeptidic part of the 
calcaripeptides was confirmed. The overall structure and the biosynthetic origin of the 
building blocks support the involvement of a hybrid between a polyketide synthase and 
nonribosomal peptide synthetase for the peptidic backbone (PKS−NRPS hybrid) in the 
formation of the calcaripeptides. An increasing number of fungal compounds have 
recently been shown to be synthesized by this type of enzyme, e.g., fusarin C, 
aspyridone, or pseurotin (Collemare et al. 2008). The genome of Calcarisporium sp. 
strain KF525 is currently under investigation with the aim of identifying genes encoding 
the respective PKS−NRPS hybrids responsible for the biosynthesis of the 
calcaripeptides. Reference sequences of the known hybrid PKS−NRPS genes from other 
fungi are available for comparison. 
Promiscuity with respect to the amino acid substrates has been shown for fungal NRPS 
in vitro and in vivo (Qiao et al. 2011, Krause et al. 2001, Xu et al. 2007). As 
promiscuity might thus be a possibility for the postulated NRPS component of the 
biosynthesis of 1−3, it was tested whether a supply of structurally related, alternative 
amino acids as substrates for the NRPS would lead to derivatives of 1. Supplementation 
of L-tryptophan, L-tyrosine, or L-histidine to the culture broth of KF525 did not result in 
 
feeding with enhancement of (enrichment) 
1-13C-acetate C-1 (3.6%), C-3 (3.3%), C-5 (3.8%),  
C-7 (3.0%), C-9 (3.2%), C-1' (1.4%), 
C-5' (1.5%) 
Me-13C-methionine 2-CH3 (63.7%), 4-CH3 (62.3%),          
6-CH3 (60.5%) 
1-
13
C-acetate 
  
SAM derived methyl group 
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their incorporation into 1 in place of L-proline or L-phenylalanine. Therefore, the 
enzymes involved in the biosynthesis of the calcaripeptides seem to be specific for their 
amino acid substrates. Additional supply of L-proline and L-phenylalanine as the 
naturally incorporated amino acids led to an increased production of 1, displaying 
potential for an optimization in the fermentation process. 
Experimental Section 
General Experimental Procedures 
Melting points were determined on an Electrothermal melting point apparatus. Optical 
rotation measurements were performed on a Perkin-Elmer model 241 polarimeter. UV 
spectra were obtained on a Perkin-Elmer Lambda 2 spectrophotometer. NMR spectra 
were recorded on Bruker DRX 500 (500 and 125 MHz for 
1
H and 
13
C NMR, 
respectively) and Bruker AV 600 spectrometers (600 and 150 MHz for 
1
H and 
13
C 
NMR, respectively), using the residual solvent signals as internal references (δH 3.31 
and δC 49.0 for methanol-d4; δH 2.05 and δC 29.8 for acetone-d6). Measurements of 
high-resolution mass spectra were conducted on a benchtop time-of-flight spectrometer 
(micrOTOF II, Bruker) with positive ESI. Analytical reversed-phase HPLC-UV/MS 
experiments were carried out on a VWR-Hitachi LaChrom Elite system consisting of an 
L-2130 pump, an L-2450 diode array detector, an L-2200 autosampler, an L-2300 
column oven, and a Phenomenex Onyx Monolithic column (C18, 100 × 3.00 mm) 
applying an H2O (A)/ MeCN (B) gradient with 0.1% HCOOH added to both solvents 
(gradient: 0 min 5% B, 4 min 60% B, 6 min 100% B; flow 2 mL min
−1
). For mass 
detections the HPLC system was coupled to an ESI-ion trap detector (Esquire4000, 
Bruker Daltonics). Preparative HPLC was performed on a VWR LaPrep system 
equipped with a P110 pump, a P311 UV detector, a Labocol Vario-2000 fraction 
collector (LABOMATIC), a Smartline 3900 autosampler (Knauer), and a Phenomenex 
Gemini-NX column (10 μ C18, 100A, Axia, 100 × 50.00 mm). Further compound 
purifications were conducted on a Merck-Hitachi LaChrom Elite HPLC system 
consisting of an L-7150 pump, an L-2450 diode array detector, an L-2200 autosampler, 
and a Phenomenex Gemini-NX column (5 μ C18, 110A, Axia, 100 × 21.20 mm). The 
eluents for all preparative HPLC separations were H2O (A) and MeCN (B) with 0.1% 
HCOOH added to both solvents. 
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Isolation and Identification of the Fungal Strain 
The strain KF525 was isolated from a water sample collected in the German Wadden 
Sea. The DNA extraction, the amplification of the internal transcribed spacer region 
(ITS), and the sequencing were performed using standard protocols (Wiese et al. 2011) 
modified in that the centrifugation was carried out at 8000g for DNA extraction, 
DreamTaq Green PCR Master Mix (2×) (Fermentas) was employed for amplification, 
35 cycles instead of 30 were conducted for amplification, and the primer ITS4 was used 
for sequencing. The DNA sequence was deposited in GenBank under the accession 
number KC800713. A sequence analysis in GenBank using the Basic Local Alignment 
Search Tool (BLAST) gave 91% similarity to Calcarisporium arbuscula. A 
microscopic analysis of the strain showed structures typical of the genus 
Calcarisporium. Taken together, the sequence and morphological data allowed the 
identification of strain KF525 as a Calcarisporium sp., as was additionally confirmed 
by the Centraalbureau voor Schimmelcultures (CBS, Utrecht, The Netherlands). 
Fermentation 
Cultivation experiments were performed in 16 2-L Erlenmeyer flasks, each containing 
750 mL of modified casamino acids glucose medium (2.5 g of casein hydrolysate, 40 g 
of glucose × H2O, 0.1 g of MgSO4 × 7H2O, 1.8 g of KH2PO4 per liter of distilled H2O, 
pH 6.8) (Stevens 1974). Cultures were inoculated with a circular agar slant (1.8 cm in 
diameter) of a preculture grown on solid modified Wickerham medium (3 g of malt 
extract, 3 g of yeast extract, 5 g of peptone from soymeal, 10 g of glucose × H2O, 30 g 
of NaCl, 15 g of agar per liter of distilled H2O, pH 6.25) (Wickerham 1951). The 
preculture was incubated at room temperature in the dark for 11 days. The main cultures 
were incubated at 22 °C under shaking conditions (120 rpm) in the dark for 24 days. 
Purification of Calcaripeptides A−C 
The culture broth of KF525 was separated into the culture supernatant and the 
mycelium. The culture filtrate was extracted with EtOAc. The organic solvent was 
evaporated to dryness in vacuo to give 0.92 g of extract. The extract was fractionated by 
preparative HPLC on a VWR LaPrep system (gradient: 0 min 10% B, 17 min 60% B, 
22 min 100% B; flow 100 mL min
−1
; UV detection at 217 nm), yielding three fractions 
that contained the calcaripeptides (tR 15.7, 16.6, and 17.6 min). These fractions were 
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further purified on a Merck-Hitachi LaChrom Elite system to give 117.9 mg of 1 
(isocratic: 42% B; flow 18 mL min
−1
; UV detection at 220 nm; tR 10.7 min), 6.2 mg of 2 
(isocratic: 29% B; UV detection at 205 nm; tR 27.5 min), and 8.5 mg of a compound 
mixture containing 3 (gradient: 0 min 40% B, 13 min 65% B; flow 18 mL min
−1
; UV 
detection at 205 nm; tR 6.2 min). Compound 3 was subjected to a third preparative 
HPLC purification on the same system (gradient: 0 min 40% B, 13 min 80% B; flow 18 
mL min
−1
; UV detection at 205 nm; tR 5.8 min), resulting in a yield of 5.7 mg. 
Calcaripeptide A (1): white needles or amorphous solid (MeOH); mp 199−201 °C; 
[α]20D −133 (c 1.4, MeOH); UV (MeOH) λmax (log ε) 201 (4.43), 230 (sh) (4.14) nm; 1D 
and 2D NMR data, see Table I.1; HRESIMS m/z 469.2707 [M + H]
+
 (calcd for 
C27H37N2O5, 469.2697). 
Calcaripeptide B (2): colorless oil; [α]20D −113 (c 0.31, MeOH); UV (MeOH) λmax (log 
ε) 201 (4.35) nm, 230 (sh) (4.09); 1D and 2D NMR data, see Table I.2 and SI; 
HRESIMS m/z 455.2538 [M + H]
+
 (calcd for C26H35N2O5, 455.2541). 
Calcaripeptide C (3): colorless oil; [α]20D −79 (c 0.2, MeOH); UV (MeOH) λmax (log ε) 
201 (4.24) nm; 1D and 2D NMR data, see Table I.2 and SI; HRESIMS m/z 429.2379 
[M + H]
+
 (calcd for C24H33N2O5, 429.2384). 
X-ray Crystal Structure Determination 
Data collection was performed using an imaging plate diffraction system (IPDS-2) from 
STOE & CIE at 293 K using Mo Kα radiation (γ = 0.71073 Å). Formula: C27H36N2O5, 
molecular weight: 468.58 g mol
−1
, monoclinic, space group C2; unit cell dimensions: a 
= 44.5917(12) Å, b = 9.6204(2) Å, c = 37.0616(10) Å, β = 122.453(2)°, V = 13416.1(6) 
Å
3
, Z = 20, Dcalcd = 20, 1.160 Mg/m
3
, μ = 0.080 mm-1. The structure was solved with 
methods using SHELXS-97, and refinement was performed against F
2
 using SHELXH. 
All non-hydrogen atoms were refined anisotropically. The H atoms were positioned 
with idealized geometry and refined isotropically with Uiso(H) = 1.2Ueq(C,N) using a 
riding model (1.5 for methyl H atoms). A total of 27 668 reflections were measured in 
the range of 2θ 1.2−24.6°, of which 11 536 are independent (Rint = 0.0347), 1531 
parameters, GOF = 1.080, R1 for 8490 reflections with I > 2σ(I) = 0.0521, wR2 for all 
reflections = 0.1205. Residual electron density = 0.326/0.164 e/Å
3
. In one of the five 
independent molecules slightly enlarged anisotropic displacement parameters are 
observed for some C atoms, indicating disorder that cannot be resolved successfully. 
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Because no strong anomalous scattering atoms are present, the absolute structure and 
absolute configuration cannot be determined, and therefore, Friedel equivalents were 
merged in the refinement. 
Crystallographic data for 1 have been deposited with the Cambridge Crystallographic 
Data Centre (CCDC-943694). Copies of the data can be obtained, free of charge, on 
application to the Director, CCDC, 12 Union Road, Cambridge CB2 1EZ, UK (fax: 
+44-(0)1223-336033 or e-mail: deposit@ccdc.cam.ac.uk). 
Preparation and Analysis of D- and L-FDVA Derivatives 
The hydrolysis of 1 was achieved by dissolving 2.7 mg of the compound in 1.5 mL of 6 
N HCl and subsequent heating at 110 °C overnight. The reaction mixture was then 
concentrated to dryness and redissolved in 250 μL of H2O. For the derivatization, 50 μL 
of the hydrolysate solution was mixed with 100 μL of a 1% (w/v) solution of D-FDVA 
(N
α
-(2,4-dinitro-5-fluorophenyl)-D-valinamide) in acetone. After addition of 40 μL of 1 
M NaHCO3 and 70 μL of DMSO, the mixture was incubated at 60 °C for 2 h. The 
reaction was stopped by addition of 30 μL of 2 M HCl. The amino acid standards (50 
mM L-proline and L-phenylalanine) were derivatized with D-FDVA and L-FDVA in the 
above-described manner. Prior to analytical HPLC-UV/MS analyses the reaction 
mixtures were diluted 100-fold with MeOH/H2O (1:1). The retention times (min) of the 
amino acid standard derivatives were as follows: D-FDVA-L-Pro (3.69), L-FDVA-L-Pro 
(3.48), D-FDVA-L-Phe (4.50), and L-FDVA-L-Phe (4.07). The HPLC analysis of the 
hydrolysate D-FDVA derivatives showed peaks at 3.69 and 4.50 min. An additional 
confirmation of the amino acid configuration was accomplished by spiking the 
hydrolysate derivatives with the amino acid standard derivatives. 
Biosynthetic Studies 
For the feeding experiments, Calcarisporium sp. strain KF525 was cultivated as 
described in the Fermentation Section above. Precultures were 7 to 15 days old. Each 
feeding experiment was performed in one 2-L Erlenmeyer flask, containing 750 mL of 
medium. After five days of cultivation 
13
C-labeled compounds were added as sterile 
filtered, aqueous solutions (500 mg of sodium acetate-1-
13
C, Isotec or 250 mg of L-
methionine-methyl-
13
C, Cambridge Isotope Laboratories). For the extraction, the 
supernatant and the mycelium of the cultures were separated after 21 days of 
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incubation. The culture filtrate was extracted with EtOAc as described above, while the 
mycelium was extracted with EtOH. The culture filtrate fed with 
13
C-labeled acetate 
was purified on a Merck-Hitachi LaChrom Elite system (gradient: 0 min 28% B, 30 min 
61% B; flow 18 mL min
−1
; UV detection at 230 nm; tR 17.9 min) to give 8.2 mg of 1.  
In the feeding experiment with 
13
C-labeled methionine, compound 1 was isolated from 
the extracts of both the culture filtrate and the mycelium. Afterward, purified 1 was 
combined for NMR spectroscopy studies. The extract of the culture filtrate was 
separated on a Merck-Hitachi LaChrom Elite system (gradient: 0 min 28% B, 20 min 
50% B; flow 18 mL min
−1
; UV detection at 230 nm; tR 14.7 min), yielding 1.6 mg of 1. 
The purification of compound 1 from the extract of the mycelium was conducted on the 
same system (gradient: 0 min 35% B, 20 min 50% B, 20.5 min 70% B, flow 18 mL 
min
−1
; UV detection at 230 nm; tR 12.7 min) with a yield of 0.6 mg. 
Feeding Alternative Amino Acids 
Each amino acid experiment was performed in one 2-L Erlenmeyer flask, containing 
750 mL of medium. Culture conditions and medium were the same as described in the 
Fermentation Section above. After five days of cultivation the respective amino acid 
was added as a sterile filtered, 50 mL aqueous solution (end concentration in culture 
medium: 1 g L
−1
). The added amino acids were L-tryptophan, L-tyrosine, L-histidine, L-
proline, L-phenylalanine, and L-proline plus L-phenylalanine. L-Tyrosine did not 
dissolve completely, and only the dissolved portion was added to the culture. Two 
cultures without additionally supplied amino acids served as controls in the experiment. 
The culture filtrate was extracted with EtOAc as described above, while the mycelium 
was extracted with EtOH. The extracts were analyzed by analytical HPLC-UV/MS.  
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Abstract 
Bioactive compounds were detected in crude extracts of the fungus, Calcarisporium sp. 
KF525, which was isolated from German Wadden Sea water samples. Purification of 
the metabolites from the extracts yielded the five known polyesters, 15G256α, α-2, β, β-
2 and π (1–5), and five new derivatives thereof, named calcarides A–E (6–10). The 
chemical structures of the isolated compounds were elucidated on the basis of one- and 
two-dimensional NMR spectroscopy supported by UV and HRESIMS data. The 
compounds exhibited inhibitory activities against Staphylococcus epidermidis, 
Xanthomonas campestris and Propionibacterium acnes. As the antibacterial activities 
were highly specific with regard to compound and test strain, a tight structure-activity 
relationship is assumed. 
Introduction 
Fungal species of the genus, Calcarisporium, have a widespread occurrence and are 
frequently found as mycoparasites or symbiotes of higher fungi (Sutton 1973, 
Somrithipol and Jones 2006, Ji et al. 2004, Kramer et al. 1959, Watson 1955). The 
Calcarisporium sp. strain KF525 investigated in this study was isolated from a water 
sample taken in the German Wadden Sea. It showed a diverse chemical profile, 
including ten structurally closely related compounds of the 15G256-type known as, e.g., 
15G256α (1) or α-2 (2) (Figure II.1; to be differentiated from the structural class 
comprising 15G256γ, δ and ε). 
The 15G256-type compounds are produced by a number of fungi, such as ascomycetes, 
like Hypoxylon, Penicillium, Talaromyces, Acremonium and Scedosporium species, as 
well as by the basidiomycete, Albatrellus confluens (Schlingmann et al. 2002, Breinholt 
et al. 1993, Ito et al. 1992a, Roy et al. 1996, Kondo et al. 1993, Arai et al. 2002, Zhou et 
al. 2009). Since some metabolites were isolated independently from the different 
producer strains, renaming occurred among the 15G256-type compounds. 15G256α (1) 
is synonymous with BK233-A and NG-012, 15G256α-1 is a synonym of BK233-B and 
probably NG-011 (discussed in Schlingmann et al. 2002), while 15G256β (3) was also 
named orbuticin, BK233-C and BE-26263 (Schlingmann et al. 2002, Breinholt et al. 
1993, Roy et al. 1996, Kondo et al. 1993, Ito et al. 1992b). With regard to the chemical 
structures, the compounds are polyesters that occur either in closed ring structures as 
macrocycles or as linear molecules (Figure II.1). Schlingmann et al. (2002) proposed a 
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Figure II.1. Compounds isolated from Calcarisporium sp. KF525: 
15G256α, α-2, β, β-2 and π (1–5) and calcarides A–E (6–10). 
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biosynthesis route in which 6-hydroxymellein and β-hydroxybutyric acid (Figure II.2) 
are the precursors of the 15G256 components, forming the acyclic polyesters in the first 
instance. In later biosynthetic steps, the macrocyclic 15G256 compounds arise from the 
linear polyesters by ring closure reactions (Schlingmann et al. 2002). Various biological 
activities have been ascribed to the 15G256 agents, including antifungal, estrogenic and 
cytotoxic properties, as well as they were shown to potentiate nerve growth factor-
induced neurite outgrowth (Schlingmann et al. 2002, Breinholt et al. 1993, Ito et al. 
1992a, Roy et al. 1996, Kondo et al. 1993). For example, 15G256α (1), α-1 and β (3) 
attracted attention in the field of crop protection, as they displayed antifungal properties 
against important plant pathogenic fungi, e.g., Botrytis cinerea or Monilinia fructigena 
(Breinholt et al. 1993). 
 
 
 
 
 
 
 
 
 
 
 
Here, we report the isolation of five known (1–5) and five new (6–10) 15G256-type 
compounds from Calcarisporium sp. strain KF525. Their structure elucidation and 
antibacterial activities are described. 
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Results and Discussion 
Isolation and Structure Elucidation 
The fungal strain KF525 is a Calcarisporium sp. that is a part of the marine fungal 
strain collection of the Kiel Center for Marine Natural Products (Silber et al. 2013). 
Extracts of cultures from the Calcarisporium sp. strain KF525 grown in modified 
casamino acids glucose medium (Stevens 1974) showed antibacterial activities and 
were investigated in detail. Fractionation of these extracts by preparative reversed-phase 
HPLC yielded the known compounds, 15G256α, α-2, β, β-2 and π (1–5), as well as five 
new derivatives thereof, calcarides A–E (6–10) (Figure II.1). 
The structures of 1–5 were identified by comparison of their spectroscopic data (UV, 
MS and 
1
H NMR spectra) with those described in the literature (Schlingmann et al. 
2002). As the data agreed well with the values published, the structures of 1–5 were 
assigned as shown in Figure II.1. 
The molecular formula of calcaride A (6) was determined to be C33H40O14 by high-
resolution ESIMS measurements (measured 661.2503, calculated 661.2491 [M + H]
+
). 
The structure of 6 was elucidated on the basis of one- and two-dimensional NMR 
spectra (
1
H, 
13
C, DEPT, COSY, HSQC and HMBC, see Table II.1). The NMR spectra 
of 6 were measured in acetone-d6, as it did not dissolve well in methanol-d4, whereas 
NMR data of all other calcarides were recorded in methanol-d4. The analysis of the 
NMR data of 6 revealed considerable structural similarities with 15G256β (3). The 1H 
NMR spectrum, the 
1
H NMR coupling constants and the 
13
C NMR spectrum of 6 
showed that, comparable to 3 (Schlingmann et al. 2002, Breinholt et al. 1993), the 
compound was composed of two phenyl moieties with their two protons in meta 
position to each other and five methyl, five methylene, five methine and five ester 
carbonyl groups. The two-dimensional NMR spectra of 6 proved that the 
Figure II.2. Proposed biosynthetic precursors of the calcarides 
(based on the proposal of Schlingmann et al. 2002). 
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aforementioned functional groups were connected exactly as in 3, forming a cyclic 
pentalactone. A mass difference of 14 between 6 and 3 indicated the presence of an 
additional methyl group in 6, which was corroborated by additional signals for a methyl 
group in the 
1
H and 
13
C NMR spectra. The chemical shifts of the respective proton and 
carbon resonances (δH 3.82 ppm, δC 55.8 ppm) determined it to be a methoxy group. 
The proton signal of the methoxy group correlated with C-9 in the HMBC NMR 
spectrum. Thus, the structure of 6 was identified as the methylated derivative of 3, with 
the methyl group attached to the hydroxyl group of C-9. 
The molecular formula of calcaride B (7) was deduced to be C33H40O15 by high-
resolution ESIMS measurements (measured 677.2435, calculated 677.2440 [M + H]
+
). 
UV and NMR spectra of 7 (Tables II.2 and II.3) strongly resembled those of 6. The 
NMR spectra of 7 showed all resonances as those of 6, apart from one striking 
difference: the signals in position 32 corresponded to a methylene instead of a methyl 
group. The downfield shift of the proton and carbon signals of CH2-32 (δH 3.65 and 
3.58 ppm, δC 63.6 ppm) suggested the attachment of a hydroxyl group to C-32 in 7. This 
was in full accordance with a mass increase of 16 mass units in comparison to 6 and 
determined 7 to be the methylated analog of the known compound, 15G256α (1). 
Calcaride C (8) was found to have a molecular formula of C33H40O15 by means of high-
resolution ESIMS measurements (measured 677.2441, calculated 677.2440 [M + H]
+
). 
Thus, 7 and 8 had the same molecular formula, showing that the closely related 
compounds were structural isomers, as was confirmed by comparison of the NMR 
spectra of the two compounds (Tables II.2 and II.3). For two of the known 15G256 
components, 15G256α (1) and 15G256α-1 (Figure II.3), a comparable regioisomerism 
was observed in which either β- or γ-hydroxyester linkages lead to the ring closure of the 
compound (Schlingmann et al. 2002). 
 
 
 
 
 
Figure II.3. Structure of 15G256 α-1 (Schlingmann et al. 2002).  
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Table II.1. NMR spectroscopic data (500 MHz, acetone-d6) of calcaride A (6). 
Position δC, Type δH, Mult. (J in Hz) COSY HMBC 
1 170.09, C       
2a     40.6, CH2 2.91, dd (6.7, 16.3) 2b, 3 1, 3, 4 
2b  2.74, dd (6.4, 16.3) 2a, 3 1, 3, 4 
3     70.1, CH
a
 5.56, m 2a, 2b, 4 1, 2, 4, 5 
4     20.0, CH3 1.450, d (6.4) 3 1, 2, 3 
5   171.0, C    
6   106.9, C    
7   165.5, C    
8   100.4, CH 6.36, d (2.6) 10 5, 6, 7, 9, 10 
9   164.8, C    
OCH3     55.8, CH3 3.82, s  9 
10   111.9, CH 6.44, d (2.6) 8 5, 6, 8, 9, 12 
11   142.9, C    
12a     41.7, CH2 3.547, dd (6.8, 13.3) 12b, 13 6, 10, 11, 13, 14 
12b  2.98, dd (7.5, 13.3) 12a, 13 6, 10, 11, 13, 14 
13     73.1, CH 5.05, m
b
 12a, 12b, 14 11, 12, 14, 15 
14     19.7, CH3 1.19, d (6.2) 13 12, 13 
15 170.12, C    
16a   41.02, CH2 2.90, dd (6.3, 15.8) 16b, 17 15, 17, 18 
16b  2.72, dd (7.1, 15.8) 16a, 17 15, 17, 18 
17     70.0, CH
a
 5.52, m 16a, 16b, 18 15, 16, 18, 19 
18     20.1, CH3 1.454, d (6.4) 17 15, 16, 17 
19   170.9, C    
20   105.6, C    
21   165.9, C    
22   102.6, CH 6.30, d (2.5) 24 19, 20, 21, 23, 
24 23   163.1, C    
24   113.3, CH 6.35, d (2.5) 22 19, 20, 22, 23, 
26 25   143.3, C    
26a     42.4, CH2 3.553, dd (5.7, 12.9) 26b, 27 20, 24, 25, 27, 
28 26b  2.78, dd (8.6, 12.9) 26a, 27 0, 24, 25, 27, 
28 27     72.5, CH 5.01, m
b
 26a, 26b, 28 5, 26, 28, 29 
28     19.5, CH3 1.14, d (6.2) 27 26, 27 
29   170.2, C    
30a   41.01, CH2 2.63
c 
30b, 31 29, 31, 32 
30b  2.63
c 
30a, 31 29, 31, 32 
31     68.4, CH 5.28, m 30a, 30b, 32 1, 29, 30, 32 
32     19.9, CH3 1.27, d (6.3) 31 29, 30, 31 
a
Assignments of C-3 and C-17 are interchangeable. 
b
Signals overlap and are deduced from the 
HSQC NMR spectrum. 
c
Signals overlap. 
Given that 7 is the methylated form of 1, it was assumed that 8 was the methylated 
derivative of 15G256α-1. The NMR spectra of 8 confirmed the assumption, since the 
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signals were in good agreement with those reported for 15G256α-1 (Schlingmann et al. 
2002). An additional resonance for a methoxy group in the NMR spectra of 8 
determined it to be the methyl ether of 15G256α-1. As the assignments of C-7 (δC 
165.08 ppm) and C-9 (δC 165.0 ppm) might be interchangeable, the position of the 
methoxy group that showed a correlation to either of the two signals in the HMBC 
spectrum could not unambiguously be determined. In analogy to 6, 7, 9 and 10, where 
the methyl group was linked to the hydroxyl group of C-9, it was deduced that this is 
also most likely to be the case for compound 8. In addition to being regioisomers, it was 
observed that 7 and 8 interconverted during storage as dried compounds, with 7 
showing a purity of about 75% after a period of two weeks. At the same time, 
compound 8 had converted into 7 more slowly and showed a purity of around 85%. 
These percentages were stable over a period of three months in which the compound 
stability was studied.  
The molecular formula of calcaride D (9) was determined as C33H42O16 on the basis of  
high-resolution ESIMS measurements (measured 693.2405, calculated 693.2400 [M − 
H]
−
), requiring 13 degrees of unsaturation. The NMR spectra of 9 (Tables II.3 and II.4) 
showed signals for the two phenolic substructures characteristic of the calcarides and 
five carbonyl resonances, together accounting for 13 double bond equivalents. These 
data suggested a ring opening for 9, giving the structure of a linear polyester, as has 
been found among the 15G256 components, as well, e.g., 15G256α-2 (2), β-2 (4) and π 
(5). MS and NMR spectra proved 9 to be the methylated analog of 2. For the linear 
calcarides (9 and 10), the NMR spectra recorded in methanol-d4 gave one single signal 
for the aromatic protons of H-8 and H-10 (δH 6.33 ppm). Therefore, the position of the 
carbon signals of C-7 and C-9 (δC 166.0 and 165.0 ppm) could not be differentiated by 
the HMBC correlations of the aromatic protons resonances. As a consequence, the 
methoxy group showing a clear HMBC correlation to the signal at 165.0 ppm could 
have been attached to either C-7 or C-9. In order to determine the position of the 
methoxy group of 9, additional NMR spectra were recorded in chloroform-d1 in which 
signals of H-8 and H-10 appeared separately. The HMBC NMR spectrum displayed 
correlations of H-8 to C-7 and C-9 and of H-10 to C-9 and C-12. Thereby, the positions of 
the signals for C-7 and C-9 could be assigned. Consequently, the methoxy group for 
which the HMBC NMR spectrum displayed a correlation to the resonance of C-9 had to 
be attached to C-9, as shown in Figure II.1. 
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Table II.2. 
1
H NMR spectroscopic data of calcarides A–C (6–8) (500 
MHz, acetone-d6 for 6; 500 MHz, methanol-d4 for 7–8). 
  Calcaride A (6)  Calcaride B (7)  Calcaride C (8) 
Position δH, Mult. (J in Hz)  δH, Mult. (J in Hz)  δH, Mult. (J in Hz) 
2a 2.91, dd (6.7, 16.3)  2.88, dd (7.7, 16.6)  2.878, dd (8.1, 16.2) 
2b 2.74, dd (6.4, 16.3)  2.73, d (5.3, 16.6)  2.79, dd (4.8, 16.2) 
3 5.56, m  5.56, m  5.59, m 
4 1.450, d (6.4)  1.42, d (6.3)  1.44, d (6.4) 
8 6.36, d (2.6)  6.30, d (2.6)  6.31, d (2.6) 
OCH3 3.82, s  3.75, s  3.74, s
a
 
10 6.44, d (2.6)  6.36, d (2.6)  6.35, d (2.6) 
12a 3.547, dd (6.8, 13.3)  3.34
b
  3.35
c
 
12b 2.98, dd (7.5, 13.3)  2.96, dd (6.4, 13.8)  2.99, dd (6.6, 14.0) 
13 5.05, m
d
  5.07, m  5.16, m 
14 1.19, d (6.2)  1.20, d (6.2)  1.22, d (6.2) 
16a 2.90, dd (6.3, 15.8)  2.81, dd (7.6, 15.8)  2.85, dd (6.6, 16.0) 
16b 2.72, dd (7.1, 15.8)  2.67, dd (5.7, 15.8)  2.69, dd (6.6, 16.0) 
17 5.52, m  5.49, m  5.48, m 
18 1.454, d (6.4)  1.40, d (6.4)  1.39, d (6.3) 
22 6.30, d (2.5)  6.22, s  6.21, d (2.5) 
24 6.35, d (2.5)  6.22, s  6.23, d (2.5) 
26a 3.553, dd (5.7, 12.9)  3.32
b
  3.31
c
 
26b 2.78, dd (8.6, 12.9)  2.77, dd (8.1, 13.3)  2.885, dd (6.9, 13.4) 
27 5.01, m
d
  4.98, m  5.03, m 
28 1.14, d (6.2)  1.11, d (6.2)  1.16, d (6.2) 
30a 2.63
e 
 2.68, dd (5.1, 16.7)  2.51, dd (6.0, 15.3) 
30b 2.63
e 
 2.64, dd (8.1, 16.7)  2.43, dd (7.2, 15.3) 
31 5.28, m  5.28, m  4.17, m 
32a 1.27, d (6.3)  3.65, dd (4.5, 11.9)  4.12, dd (4.8, 11.1) 
32b    3.58, dd (5.1, 11.9)  4.08, dd (5.5, 11.1) 
a
Position of the methoxy group could not unambiguously be determined. In analogy to the 
other calcarides, it was assumed to be linked to C-9. 
b
Signal partially obscured and deduced 
from the HMBC NMR spectrum. 
c
Signal partially obscured. 
d
Signals overlap and are 
deduced from the HSQC NMR spectrum. 
e
Signals overlap. 
The molecular formula of calcaride E (10) was determined to be C33H42O15 by high-
resolution ESIMS measurements (measured 677.2467, calculated 677.2451 [M − H]−). 
The structure of 10 was readily deduced by comparing the NMR data (Tables II.3 and 
II.4) with those of 9. In contrast to the hydroxylated methylene group at C-32 in 9, the 
corresponding signals in the NMR spectra of 10 gave evidence for a methyl group not 
adjacent to oxygen. The position of the methoxy group at C-9 was determined 
according to additionally recorded NMR spectra in chloroform-d1, as described for 9. 
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Hence, the structure of 10 was established as the dehydroxylated form of 9, which could 
equivalently be described as the methylated analog of 4. 
Table II.3. 
13
C NMR shifts of calcarides A–E (6–10) (125 MHz, acetone-d6 for 6; 125 MHz, 
methanol-d4 for 7–9; 150 MHz, methanol-d4 for 10). 
  Calcaride A (6)  Calcaride B (7)  Calcaride C (8)  Calcaride D (9)  Calcaride E (10) 
Position δC  δC  δC  δC  δC 
1 170.09  171.5
a
  171.6  173.9
b
  175.9
b
 
2 40.6  41.0  41.2  41.8  43.3 
3 70.1
c
  70.2  70.5  70.8  71.5 
4 20.0  20.2  20.2  20.1  20.3 
5 171.0  171.13  171.53
d
  171.5
e
  171.56
f
 
6 106.9  108.7  108.2  107.2  107.3 
7 165.5  164.6  165.08
g,h
  166.0
i
  166.0
j
 
8 100.4  100.7  100.7  100.8  100.8 
9 164.8  164.9  165.0
h
  165.0
i
  165.0
j
 
OCH3 55.8  55.8  55.8
k
  55.9  55.9 
10 111.9  111.5  111.3  112.8  112.8 
11 142.9  142.6  142.7  143.2  143.3 
12 41.7  41.8  41.7  43.2  43.4 
13 73.1  73.6  73.2  73.1  73.2 
14 19.7  20.0  20.0  20.52  20.6 
15 170.12  171.37
a
  171.3
d
  171.2  171.2 
16 41.02  41.6  41.6
l
  41.8  41.8 
17 70.0
c
  70.4  70.3  70.0  70.0 
18 20.1  20.2  20.1  19.9  19.9 
19 170.9  171.07  171.48
d
  171.6
e
  171.62
f
 
20 105.6  106.7  107.3  105.8  105.7 
21 165.9  165.4  165.14
g
  166.2  166.3 
22 102.6  102.8  102.7  102.7  102.7 
23 163.1  163.5  163.4  163.5  163.6 
24 113.3  113.3  112.6  113.8  113.9 
25 143.3  143.2  143.1  143.7  143.7 
26 42.4  42.3  41.5
l
  43.5  43.6 
27 72.5  73.5  73.6  72.7  72.6 
28 19.5  19.5  19.8  20.49  20.6 
29 170.2  171.43
a
  171.9  172.7  172.5 
30 41.01  36.7  40.4  39.9  45.1 
31 68.4  72.7  67.1  69.9  65.4 
32 19.9  63.6  68.5  66.4  23.0 
a,c–j,l
Assignments are interchangeable. 
b
Signal deduced from the HMBC NMR spectrum. 
k
Position of the 
methoxy group could not unambiguously be determined. In analogy to the other calcarides it was assumed to be 
linked to C-9. 
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Table II.4. 
1
H NMR spectroscopic data of calcarides D 
and E (9 and 10) (500 MHz, methanol-d4 for 9; 600 
MHZ, methanol-d4 for 10). 
  Calcaride D (9)  Calcaride E (10) 
Position δH, Mult. (J in Hz)  δH, Mult. (J in Hz) 
2a 2.767, dd (7.5, 15.8)  2.72, dd (7.8, 15.4) 
2b 2.69, dd (5.3, 15.8)  2.61, dd (5.9, 15.4)
a
 
3 5.57, m  5.58, m 
4 1.43, d (6.4)  1.43, d (6.3) 
8 6.33, s  6.33, s 
OCH3 3.77, s  3.77, s 
10 6.33, s  6.33, s 
12a 3.29
b
  3.35, dd (3.5, 13.6)
a
 
12b 2.91, dd (9.7, 13.7)  2.87, dd (9.8, 13.6) 
13 5.22, m  5.22, m 
14 1.25, d (6.2)  1.26, d (6.3) 
16a 2.66, dd (7.2, 15.7)  2.65, dd (7.2, 15.6) 
16b 2.62, dd (5.8, 15.7)  2.62, dd (6.0, 15.6) 
17 5.47, m  5.47, m 
18 1.30, d (6.4)  1.30, d (6.3) 
22 6.203, d (2.6)  6.19, d (2.5) 
24 6.197, d (2.6)  6.18, d (2.5) 
26a 3.17, dd (4.0, 13.4)  3.20, dd (3.8, 13.5) 
26b 2.772, dd (9.2, 13.4)  2.74, dd (9.5, 13.5) 
27 5.15, m  5.14, m 
28 1.23, d (6.2)  1.23, d (6.2) 
30a 2.47, dd (5.2, 15.4)  2.36, dd (6.9, 14.7) 
30b 2.27, dd (7.9, 15.4)  2.26, dd (6.5, 14.7) 
31 3.94, m  4.02, m 
32a 3.44, dd (4.9, 11.2)  1.05, d (6.2) 
32b 3.40, dd (5.7, 11.2)    
a
Signal partially obscured. 
b
Signal partially obscured and is deduced 
from the HSQC NMR spectrum. 
Because 6–10 were methylated forms of known compounds, it had to be ruled out that 
they were artifacts arising from the extraction protocol employing methanol as the 
solvent. The first indication that this was not the case for 6–10 was that the four 
demethylated analogs 1–4, which were, as well, isolated from Calcarisporium sp. 
KF525, stayed demethylated when stored as methanolic solutions for time periods of 
more than two weeks. The final proof was that the isolation of 6–10 was likewise 
possible, when the use of methanol was avoided in all extraction steps and acetonitrile 
was employed instead. For this purpose, the presence of 6–10 was confirmed by using 
HPLC-UV/MS fingerprints of extracts from methanol and acetonitrile. 
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Absolute configurations of 6–10 were investigated by measurements of the optical 
rotation. The obtained values for optical activity were compared to those described for 
the demethylated analogs. The optical rotation data of 6–8 ([α]22D −23.6, −25.3 and 
−7.9, respectively) were in good agreement with the reported ones of the corresponding 
demethylated forms, 3, 1 and 15G256α-1 (Schlingmann et al. 2002, Breinholt et al. 
1993, Ito et al. 1992a, Roy et al. 1996). Even though some of the published values 
referred to ethanol solutions or higher temperatures employed for the measurements, 
they were consistent with our data. Hence, the absolute configurations of 6–8 were 
suggested to be the same as for their published demethylated forms (Schlingmann et al. 
2002). For 2 and 4, which are the demethylated derivatives of 9 and 10, there is no 
literature record of optical rotation values. Thus, a comparison with published data was 
not possible, but as 2 and 4 were also isolated from Calcarisporium sp. KF525, their 
optical rotation was measured ([α]22D −77.8 for 2; [α]
22
D −76.9 for 4) and compared 
with the values of 9 and 10 ([α]22D −71.8 and −67.3, respectively). As a result, the 
stereochemistry of 9 and 10 was assumed to be identical to the stereochemistry for 2 
and 4 proposed by Schlingmann et al. (2002) (Figure II.1). 
From a biosynthetic perspective, the precursors of the known 15G256 components are  
6-hydroxymellein and β-hydroxybutyric acid (Schlingmann et al. 2002). Consequently, 
the building blocks of the calcarides should be 6-methoxymellein additional to 6-
hydroxymellein and β-hydroxybutyric acid (Figure II.2). 6-methoxymellein is a natural 
product known from a variety of fungi, e.g., Aspergillus and Ceratocystis species 
(Dictionary of Natural Products 2012). Both, 6-methoxy- and 6-hydroxy-mellein were 
found in crude extracts of Calcarisporium sp. KF525, according to UV and MS spectra 
from analytical HPLC-UV/MS analyses. The position of the methoxy and hydroxyl 
groups in the mellein structure could not be deduced from these data and was only 
assumed according to the position of the respective groups in the calcarides. Given that 
the calcarides are built up by the same or methylated precursors as the 15G256 
components, the identical stereochemistry in calcaride and 15G256 molecules is 
reasonable. 
Antibacterial Activity 
Compounds 1–10 were profiled against a set of bacterial strains, including the biofilm-
forming, Staphylococcus epidermidis, the plant pathogen, Xanthomonas campestris, and 
Propionibacterium acnes, which is linked to the skin disease acne. Even though the 
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compounds are closely related from a structural point of view, they show distinct 
antibacterial activities (Table II.5). All macrocyclic compounds (1, 3, 6–8) inhibited S. 
epidermidis and X. campestris, while the linear polyesters did not show any activities 
below a minimal inhibitory concentration (MIC) of 100 µM. The results indicated that a 
ring structure is required for the activity. This observation was also made for antifungal 
properties of the already known 15G256 components (Schlingmann et al. 2002). Among 
the cyclic compounds, 1 showed the highest activity against S. epidermidis ((12.9 ± 3.6) 
µM), and 6 displayed the lowest MIC for X. campestris ((5.5 ± 1.3) µM). A comparison 
of the inhibition between active methylated and demethylated forms, e.g., 1 and 7 or 3 
and 6, showed a decreased activity against S. epidermidis by a factor of four for the 
methylated analogs, whereas the activities concerning X. campestris were in the same 
concentration range. P. acnes was not inhibited by any of the tested substances, but the 
linear compound 5. Given that 5 and 4 only differ in a β-hydroxybutyrate moiety, the P. 
acnes-related activity of 5 seemed highly specific. 
Table II.5. Antibacterial minimal inhibitory concentrations 
(MICs) of compounds 1–10 and the positive control, 
chloramphenicol. Activities higher than 20% were considered as 
inhibitory. 
Compound 
S. epidermidis  
MIC [µM] 
X. campestris  
MIC [µM] 
P. acnes  
MIC [µM] 
15G256α (1) 12.9 (±3.6) 30.8 (±3.1) >100 
15G256α-2 (2) >150 >150 >200 
15G256β (3) 16.9 (±0.6) 14.9 (±7.5) >200 
16G256β-2 (4) >150 >150 >100 
15G256π (5) >150 >150 14.1 (±1.8) 
calcaride A (6) 68.8 (±3.7) 5.5 (±1.3) >200 
calcaride B (7) 52.3 (±2.3) 22.6 (±9.2) >200 
calcaride C (8) 29.6 (±1.6) 61.4 (±12.7) >100 
calcaride D (9) >150 >150 >200 
calcaride E (10) 104.3 (±7.8) >150 >100 
chloramphenicol 4.5 1.0 0.5 
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15G256 components are known to possess antifungal activities, estrogenic effects or 
cytotoxic properties with regard to cellular ATP (viability) and chemiluminescence 
(phagocytosis) in a mouse peritoneal macrophage assay, as well as they are described to 
be potentiators of the nerve growth factor in PC12 cells (Schlingmann et al. 2002, 
Breinholt et al. 1993, Ito et al. 1992a, Roy et al. 1996, Kondo el. 1993). However, no 
antibacterial activities had been observed, even when tested. Here, the 15G256 
compounds and the new methylated derivatives thereof were found to display 
antibacterial activities that are moderate in potency, but have a tight structure-activity 
relationship. Even a slight structural variation, like a methylation, as seen for the 
calcarides, influenced compound activities significantly. This was found to be true for 
other natural products (Walle et al. 2007, Liu et al. 2010). For instance, the methylation 
of the cholesterol-lowering agent, lovastatin, resulted in the improved drug, simvastatin 
(Li and Vederas 2009). Regarding simvastatin, the introduction of a methyl group was 
used as a tool, but similarly, the isolation of derivatives of known compounds can be 
used as a strategy to obtain improved lead structures. As shown for the calcarides, fungi 
are a good source for this purpose, because they often produce a bunch of structurally 
related compounds, e.g., resulting from the promiscuity of the biosynthetic enzymes 
(Grüschow et al. 2011). From the fungus’ point of view, the production of closely-
related components might be of advantage as altered activities emerge. 
Experimental Section 
General Experimental Procedures 
Optical rotation measurements were obtained on a Perkin Elmer model 241 polarimeter. 
UV spectra were measured on a Perkin Elmer Lambda 2 photometer. NMR spectra 
were recorded on a Bruker DRX 500 (500 and 125 MHz for 
1
H and 
13
C NMR, 
respectively) and a Bruker AV 600 spectrometer (600 and 150 MHz for 
1
H and 
13
C 
NMR, respectively). The residual solvent signals were used as internal references for 
NMR analyses (δH 3.31 and δC 49.0 ppm for methanol-d4; δH 2.05 and  
δC 29.8 ppm for acetone-d6, δH 7.26 and δC 77.2 ppm for chloroform-d1). High-
resolution mass spectra were measured with a Bruker micrOTOF II, applying positive 
or negative ESI mode. Analytical reversed-phase HPLC-UV/MS experiments were 
conducted on a VWR-Hitachi LaChrom Elite system equipped with an L-2130 pump, 
an L-2450 diode array detector, an L-2200 autosampler, an L-2300 column oven and a 
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Phenomenex Onyx Monolithic column (C18, 100 × 3.00 mm). A gradient with 0.1% 
formic acid in H2O (A) and 0.1% formic acid in acetonitrile (B) as solvents was applied: 
0 min 5% B, 4 min 60% B, 6 min 100% B; flow 2 mL min
−1
. For mass detection, the 
analytical HPLC system was coupled to a Bruker esquire4000 ion-trap detector. 
Preparative HPLC was performed on a VWR LaPrep system consisting of a P110 
pump, a P311 UV detector, a Labocol Vario-2000 fraction collector (LABOMATIC), a 
Smartline 3900 autosampler (Knauer) and a Phenomenex Gemini-NX column (10 μ 
C18, 100A, Axia, 100 × 50.00 mm). Subsequent compound purifications were 
performed on a Merck-Hitachi LaChrom Elite HPLC system comprised of an L-7150 
pump, an L-2450 diode array detector and an L-2200 autosampler employing a 
reversed-phase Phenomenex Gemini-NX column (5 μ C18, 110A, Axia, 100 × 21.20 
mm). 0.1% of formic acid in H2O (A) and 0.1% formic acid in acetonitrile (B) were the 
solvents used in preparative HPLC separations. 
Fungal Material 
Calcarisporium sp. KF525 is a part of the marine fungal strain collection of the Kiel 
Center for Marine Natural Products. The strain was cryo-conserved using the 
Microbank system (Pro-Lab). 
Cultivation 
Calcarisporium sp. KF525 was cultivated in 12 L of casamino acids glucose medium  
(0.25% casein hydrolysate, 4% glucose × H2O, 0.01% MgSO4 × 7H2O, 0.18% KH2PO4, 
pH 6.8) (Stevens 1974). 2-L Erlenmeyer flasks filled with 0.75 L medium were used for 
the culture experiments, which were performed for 24 days at 22 °C under shaking 
conditions (120 rpm) in the dark. A circular agar slant (1.8 cm in diameter) of a 
preculture served as the inoculum. The preculture was grown on agar plates of modified 
Wickerham medium (0.3% malt extract, 0.3% yeast extract, 0.5% peptone from 
soymeal, 1% glucose × H2O, 3% NaCl, 1.5% agar, pH 6.25) (Wickerham 1951) over a 
period of 11 days at room temperature in the dark. 
Isolation Procedure 
The cultures of Calcarisporium sp. KF525 were separated into mycelium and culture 
supernatant. An extraction of the culture supernatant with EtOAc yielded a crude extract 
of 0.92 g. The extract was subjected to the first purification step using a VWR LaPrep 
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HPLC system (gradient: 0 min 10% B, 17 min 60% B, 22 min 100% B; flow 100 mL 
min
−1
; UV detection at 217 nm). The purification gave 8 fractions containing the 
15G256 and calcaride components (tR 12.4, 13.2, 14.5, 15.7, 16.2, 17.6, 18.5 and 20.6 
min) of which fraction 8 comprised pure 6 in a yield of 17.7 mg. All other fractions 
were further purified on a Merck-Hitachi LaChrom Elite HPLC system applying 
reversed-phase chromatography. The purification of fraction 1 gave 17.8 mg of 2 
(gradient: 0 min 30% B, 13 min 40% B; flow 18 mL min
−1
; UV detection at 220 nm; tR 
6.7 min) and fraction 2 afforded 11.8 mg of 5 (gradient: 0 min 25% B, 13 min 50% B; 
flow 18 mL min
−1
; UV detection at 220 nm; tR 9.2 min). The chromatography of 
fraction 3 (gradient: 0 min 30% B, 15 min 37% B; flow 18 mL min
−1
; UV detection at 
220 nm) resulted in 14 mg of purified 4 (tR 11.1 min) and semi-pure 9 (tR 12.0 min), 
which was isolated in two additional rounds of purification to give a yield of 23.2 mg 
(1st, gradient: 0 min 30% B, 13 min 45% B; flow 18 mL min
−1
; UV detection at 220 
nm; tR 9.2 min. 2nd, isocratic: 25% B; flow 18 mL min
−1
; UV detection at 210 nm; tR 
23.2 min). Pure 1 (17.5 mg) was obtained from fraction 4 by applying two consecutive 
steps of preparative HPLC (1st, 0 min 40% B, 13 min 65% B, flow 18 mL min
−1
; UV 
detection at 205 nm; tR 5.2 min. 2nd, gradient: 0 min 30% B, 10 min 61% B; flow 18 
mL min
−1
; UV detection at 220 nm; tR 7.6 min). Fraction 5 was subjected to two further 
purification steps yielding 2.9 mg of 10 (1st, isocratic: 29% B, flow 18 mL min
−1
; UV 
detection at 220 nm; tR 21.7 min. 2nd, gradient: 0 min 27% B, 15 min 50% B; flow 18 
mL min
−1
; UV detection at 220 nm; tR 12.4 min). Fraction 6 contained compounds 7 
and 8, which were initially eluted isocratically with 42% B (flow 18 mL min
−1
; UV 
detection at 220 nm; tR 11.8 min). A subsequent round of preparative HPLC (isocratic: 
40%, flow 18 mL min
−1
; UV detection at 210 nm) gave purified 7 (tR 12.8 min) and 8 
(tR 16.0 min) in yields of 14.6 and 5.7 mg, respectively. 1.8 mg of compound 3 were 
isolated from fraction 7 by employing two chromatographic steps (1st, gradient: 0 min 
50% B, 13 min 80% B; flow 18 mL min
−1
; UV detection at 220 nm; tR 6.0 min. 2nd, 
isocratic: 45% B, flow 18 mL min
−1
; UV detection at 220 nm; tR 7.3 min.). 
Calcaride A (6): Pale yellow solid, [α]22D −23.6 (c 0.195, MeOH), UV (MeOH) λmax 
(log ε) 216 (4.57), 263 (4.27), 302 (3.92) nm; for 1D and 2D NMR data see Table II.1; 
HRESIMS m/z 661.2503 [M + H]
+
 (calcd for C33H40O14, 661.2491). 
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Calcaride B (7): White solid, [α]22D −25.3 (c 0.45, MeOH), UV (MeOH) λmax (log ε) 
216 (4.58), 263 (4.27), 302 (3.92) nm; for 1D and 2D NMR data see Tables II.2, II.3 
and SI; HRESIMS m/z 677.2435 [M + H]
+
 (calcd for C33H40O15, 677.2440). 
Calcaride C (8): White solid, [α]22D −7.9 (c 0.793, MeOH), UV (MeOH) λmax (log ε) 
216 (4.59), 263 (4.30), 302 (3.94) nm; for 1D and 2D NMR data see Tables II.2, II.3 
and SI; HRESIMS m/z 677.2441 [M + H]
+
 (calcd for C33H40O15, 677.2440). 
Calcaride D (9): White solid, [α]22D −71.8 (c 0.98, MeOH), UV (MeOH) λmax (log ε) 
216 (4.60), 263 (4.35), 302 (3.99) nm; for 1D and 2D NMR data see Tables II.3, II.4 
and SI; HRESIMS m/z 693.2405 [M − H]− (calcd for C33H42O16, 693.2400). 
Calcaride E (10): White solid, [α]22D −67.3 (c 0.05, MeOH), UV (MeOH) λmax (log ε) 
216 (4.61), 263 (4.35), 302 (3.98) nm; for 1D and 2D NMR data see Tables II.3, II.4 
and SI; HRESIMS m/z 677.2467 [M − H]− (calcd for C33H42O15, 677.2451). 
The process of interconversion of 7 and 8 was studied by periodical HPLC-UV/MS 
analyses using the mass chromatograms for quantification of the compounds’ purities. 
For the experiments, purified and dried 7 and 8 were stored at 4 °C over a time period of 
three months. 
Antibacterial Assays 
Antibacterial assays were performed using the test strains, Staphylococcus epidermidis 
(DSM20044), Xanthomonas campestris (DSM 2405) and Propionibacterium acnes 
(DSM1897).  
S. epidermidis and X. campestris were cultivated in trypticase soy broth (1.2% 
trypticase soy broth, 0.5% NaCl) overnight and diluted to an OD600 of 0.01–0.03. 10 
mM DMSO solutions of the compounds were diluted with medium to gain desired test 
concentrations. 10.5 µL of the compound solutions and 200 µL of the respective test 
strain cell suspension were transferred into a 96-well microtiter plate. Microtiter plates 
with S. epidermidis were incubated for 5 h at 37 °C in the dark, while microtiter plates 
with X. campestris were incubated for 6 h at 28 °C in the dark. After the addition of 10 
µL of a resazurin solution as the detective reagent (0.2 mg mL
−1
 in phosphate-buffered 
saline), the incubation was continued for another 5–30 min. To evaluate cell viability, 
the reduction of resazurin to resorufin was determined by measuring the intensity of 
fluorescence at 560Ex/590Em in a Tecan Infinite M200 plate reader. 
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P. acnes was grown anaerobically (Anaerocult A mini, Merck) in modified PYG 
medium (DSMZ medium 104) for 48 h at 37 °C in the dark. 2-day old cultures were 
diluted to an OD600 of 0.02. A volume of 200 µL of the cell suspension was transferred 
to a microtiter plate and mixed with 10.5 µL of the test compounds that were treated as 
described above. After an anaerobic incubation for 48 h at 37 °C in the dark, 10 µL of 
bromocresol purple (1 mg mL
−1
) were added, and the acid production of  
P. acnes was determined by measuring the absorbance at 590 nm (reference 690 nm) 
using the Infinite M200 plate reader. 
The resulting values of the antibacterial assays were compared with a positive control 
(10 µM chloramphenicol for S. epidermidis or X. campestris and 1 µM chloramphenicol 
for P. acnes) and a negative control (no compound). Minimal inhibitory concentrations 
(MICs) were defined as more than 20% inhibition of metabolic activity or acid 
production in the test strains compared to non-inhibited metabolism in the negative 
control. 
Conclusions 
Five known 15G256 components and five methylated analogs thereof were isolated 
from Calcarisporium sp. strain KF525: 15G256α, α-2, β, β-2, π (1–5) and calcarides A–
E (6–10). For the first time, antibacterial properties were detected for this type of 
natural product. The compounds showed inhibitory bioactivities against Staphylococcus 
epidermidis, Xanthomonas campestris and Propionibacterium acnes, underlying a tight 
structure-activity relationship. 15G256α (1) displayed the strongest inhibition against S. 
epidermidis, with a MIC of (12.9 ± 3.6) µM, and calcaride A (6) exhibited the lowest 
MIC for X. campestris with (5.5 ± 1.3) µM. P. acnes was specifically inhibited by the 
compound, 15G256π (5), having a MIC of (14.1 ± 1.8) µM. 
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Abstract 
The isolation and structure elucidation of malettinins A–C (1–3) along with the new 
malettinin E (4) are described. The compounds were produced by the fungus 
Cladosporium sp. strain KF501, which was isolated from the German Wadden Sea. The 
malettinins are built up of tropolone/dihydropyran ring structures linked to a furan ring. 
The structure elucidation of the isolated compounds was achieved by means of one- and 
two-dimensional NMR spectroscopy supported by mass and UV data. The relative 
configuration of 4 was determined on the basis of single-crystal X-ray diffraction 
analysis. 1–4 exhibited antibacterial and antifungal activities when profiled against 
Xanthomonas campestris and Trichophyton rubrum. The influence of the chemical 
structure of the furan ring and of configurational changes on biological activities was 
observed. 
Introduction 
The genus Cladosporium represents one of the largest and most heterogeneous genera 
of the Hyphomycetes (Bensch et al. 2012), showing ubiquitous occurrence. Species of 
the genus often have pathogenic or saprophytic lifestyles and are frequently found in 
air, soil, on foods, on plant materials or as endophytes (Stevens 1974, Samson et al. 
2000). Occurring as airborne fungi, some species of Cladosporium are of clinical 
importance as they can cause allergies such as allergic asthma (Simon-Nobbe et al. 
2008). Concerning marine habitats, a minimum of three Cladosporium species were 
described from marine sources (Kirk and Clipson 2013). Cladosporium species have 
been shown to possess the ability to produce a variety of natural products, among them 
the melanins which are pigments giving the fungal colonies their typical dark colored 
appearance. Other natural products isolated from Cladosporium species are bioactive 
compounds such as the antifungal cladosporides (Hosoe et al. 2000, Hosoe et al. 2001), 
the plant growth factors cotylenins (Sassa 1971, Sassa et al. 1975), calphostins which 
specifically inhibit the protein kinase C (Kobayashi et al. 1989) and cladosporin 
exhibiting a broad activity spectrum including antifungal, antibacterial, insecticidal, 
phytotoxic and immunosuppressive properties (Scott et al. 1971, Anke et al. 1978, 
Grove and Pople 1981, Springer et al. 1981, Fujimoto et al. 1999). 
In this study, a marine-derived Cladosporium strain was shown to produce the new 
compound malettinin E (4) along with the known malettinins A–C (1–3) (Figure III.1), 
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which have not been isolated from this genus before. The structure elucidation of the 
compounds and their biological activities are described. 
 
 
 
 
 
 
 
 
 
Material and Methods 
General Experimental Procedures 
Melting points were determined on an Electrothermal melting point apparatus. 
Measurements of optical rotation were performed on a Perkin Elmer model 241 
polarimeter. UV spectra were recorded on a Perkin Elmer Lambda 2 spectrophotometer. 
NMR spectra were measured on a Bruker AV 600 spectrometer (600 and 150 MHz for 
1
H and 
13
C NMR, respectively) and the residual solvent signals served as internal 
references (δH 3.31 and δC 49.0 for methanol-d4). High-resolution mass spectra were 
obtained on a Bruker micrOTOF II spectrometer using ESI ion source in negative mode. 
Analytical HPLC-UV/MS was conducted on a VWR-Hitachi LaChrom Elite system 
(pump L-2130, diode array detector L-2450, autosampler L-2200 and column oven L-
2300) with a Phenomenex Onyx Monolithic column (C18, 100 × 3.00 mm) applying a 
gradient of 0.1% formic acid in H2O (A) and 0.1% formic acid in acetonitrile (B): 0 min 
5% B, 4 min 60% B, 6 min 100% B; flow 2 mL min
-1
. Coupling of the HPLC system to 
a Bruker esquire4000 ESI-ion trap allowed mass detection.  
Isolation and Taxonomy of Producing Organism 
Strain KF501 was isolated from a water sample taken in the German Wadden Sea. DNA 
extraction, amplification of the internal transcribed spacer region and sequencing were 
1 2 
3 4 
Figure III.1. Structures of malettinins A–C (1–3) and 
malettinin E (4), isolated from Cladosporium sp. strain KF501. 
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performed as described by Wiese et al. (2011) with slight modifications, centrifugation 
of the DNA at 8000g and 35 cycles of DNA amplification. The DNA sequence was 
deposited in GenBank under the accession number KF923800. Cryo-conserved stock 
cultures of strain KF501 were kept at -100 °C using the Microbank system (Pro-Lab). 
Fermentation and Compound Isolation 
The fungal isolate was cultivated in the following media: Casamino acids glucose 
medium (casein hydrolysate 0.25%, glucose × H2O 4%, MgSO4 × 7H2O 0.01%, 
KH2PO4 0.18%, pH 6.8) (Stevens 1974), Czapek medium (sucrose 3%, NaNO3 0.3%, 
K2HPO4 0.1%, KCl 0.05%, MgSO4 × 7H2O 0.05%, FeSO4 × 7H2O 0.001%, pH 6.2) 
(Samson et al. 2000), modified malt extract medium (malt extract 3%, NaCl 1.5%, pH 
5.5) (Samson et al. 2000), potato-carrot medium (potatoes 40 g, carrots 40 g, each 
boiled in 1 L of H2O and filtered off, 250 mL of potato extract and 250 mL of carrot 
extract were filled up with 500 mL of distilled H2O) (Samson et al. 2000) and modified 
Wickerham medium (malt extract 0.3%, yeast extract 0.3%, peptone from soymeal 
0.5%, glucose × H2O 1%, NaCl 3%, agar 1.5%, pH 6.25) (Wickerham 1951). 
For isolation of the malettinins, Cladosporium sp. KF501 was cultivated in 9.75 L of 
casamino acids glucose medium. The cultivation experiments were performed as 
surface cultures at 20 °C in the dark in 2-L Erlenmeyer flasks, each containing 750 mL 
medium. The cultures were inoculated with an agar slant (2.6 cm in diameter) of a seven 
days old preculture, which was grown on solid, modified Wickerham medium at room 
temperature in the dark. The mycelium of strain KF501 was harvested after 40 days of 
incubation by extraction with EtOH. As the obtained extract was very greasy, fats were 
frozen out at -20 °C yielding 1.2 g of extract. 
The malettinins were purified from the mycelium extract by preparative HPLC. The 
separations were performed on a VWR LaPrep system (pump P110, UV detector P311 
UV, fraction collector Labocol Vario-2000 from LABOMATIC, autosampler Smartline 
3900 from Knauer) using a Phenomenex Gemini-NX column (10 µ C18, 100A, Axia, 
100 × 50.00 mm). A gradient of 0.1% formic acid in H2O (A) and 0.1% formic acid in 
acetonitrile (B) (0.0 min 20% B, 17.5 min 40% B, 21.0 min 60% B; flow 100 mL min
-1
) 
was applied to yield 17.5 mg of 2 (tR 8.6-9.0 min), 6.1 mg of 3 (tR 9.2-9.6 min), 4.6 mg 
of 4 (tR 9.9-10.3 min) and 15.1 mg of 1 (tR 12.2-18.0 min).   
CHAPTER III                                                                                                                                                                               65 
X-ray Crystal Structure Determination  
Single crystals of 4 suitable for X-ray data collection were obtained by recrystallization 
from a methanol solution. The data were measured using an Imaging Plate Diffraction 
System (IPDS-2) from STOE & CIE (Table III.1). All non-hydrogen atoms were 
refined anisotropically. The H atoms were positioned with idealized geometry (O-H H 
atoms allowed to rotate but not to tip) and refined isotropically with Uiso(H) = 1.2 · 
Ueq(C) (1.5 for methyl and O-H H atoms) using a riding model. There are two 
crystallographically independent molecules in the asymmetric unit, which exhibit the 
same relative configuration. In one of these molecules the H atoms of one methyl group 
are disordered and were refined using a split model with two orientations rotated by 60°. 
Because no strong anomalous scattering atoms are present, the absolute configuration 
cannot be determined. Therefore, Friedel opposites were merged in the refinement. 
Table III.1. Selected crystal data and details of the structure refinement for 4. 
Compound 4 
Formula C16H20O5 
MW / g mol
-1
 292.32 
Crystal system triclinic 
Space group P1 
a /Å 5.6652(6) 
b / Å 10.7203(10) 
c / Å 12.0282(12) 
 / ° 101.951(8) 
 / ° 97.120(8) 
 / ° 90.126 
V / Å
3
 708.87(12) 
T / K 150 
Z 2 
Dcalc / mg m
3
 1.370 
µ / mm
-1
 0.101 
max / ° 24.99 
Refl. collected 6705 
Unique refl. 2486 
Rint 0.1231 
Refl. [F0>4(F0)] 1795 
Parameters 384 
R1 [F0>4(F0)] 0.0687 
wR2 (all data) 0.1874 
GOF 1.081 
max/min / e Å
-3
 0.203 / -0-207 
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Antimicrobial Assays 
Antimicrobial assays with the test strains Xanthomonas campestris and Staphylococcus 
epidermidis were performed as described by Silber et al. (2013). Bacillus subtilis and 
Candida albicans were tested as described by Ohlendorf et al. (2012). For antifungal 
assays using Trichophyton rubrum, cultivation was carried out in modified Sabouraud 
medium (peptone 1%, glucose 2%, pH 5.6). A spore solution containing 5 × 10
4
 spores 
of T. rubrum per mL medium was prepared. 10 mM DMSO solutions of compounds 
were diluted with medium to achieve the desired test concentrations. For assaying, 200 
µL of the spore solutions were mixed with 10.5 µL of compound solutions in 96-well 
microtiter plates and incubated for 72 h at 28 °C in the dark. The cell growth of T. 
rubrum was evaluated by measuring the optical densities with a Tecan Infinite M200 
plate reader. The resulting values were compared with a positive control (0.1 and 0.5 
µM clotrimazole) and a negative control (no compound). IC50 values were determined 
according to the inhibition of metabolic activity or cell growth in the presence of a 
compound as compared to the non-inhibited negative control.  
Results 
Taxonomy of Producing Organism 
Strain KF501 was isolated from water samples taken in the German Wadden Sea. The 
strain grew well in casamino acids glucose, Czapek and malt extract medium, slowly in 
potato-carrot medium and did not grow in liquid modified Wickerham medium. In 
general, the growth of strain KF501 was relatively slow by comparison with other 
fungal isolates. 
Macroscopic and microscopic morphological features, colony color and structure of 
conidiophores were characteristic of Cladosporium spp. (Samson et al. 2000). This 
classification was corroborated by the comparison of the ITS DNA sequence of strain 
KF501 with sequences available at GenBank employing the Basic Local Alignment 
Search Tool (BLAST) (Altschul et al. 1990). The search resulted in 100% similarity to 
Cladosporium cladosporioides, C. pseudocladosporioides, C. uredinicola, C. bruhnei 
and C. colombiae. Hence, strain KF501 could be identified as a member of the genus 
Cladosporium, but identification to the species level was not possible. 
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Structure Elucidation 
The new malettinin E (4) along with the known malettinins A–C (1–3) was obtained 
from the mycelia extracts of Cladosporium sp. strain KF501 grown in casamino acids 
glucose medium. The compounds were isolated by preparative reversed-phase HPLC. 
The structures of compounds 1–3 were readily identified by spectroscopic methods 
including 
1
H NMR, UV and MS spectra (Angawi et al. 2003, Angawi et al. 2005). 
Table III.2. Physico-chemical properties of malettinin E (4). 
 Malettinin E (4) 
Appearance Orange crystals or amorphous solid (MeOH) 
Molecular formula C16H20O5 
Molecular weight 292 
HRESIMS (m/z)  
     Measured [M + H]
+ 
293.1391 
     Calculated [M + H]
+
 293.1384 
UV λmax (MeOH) nm (log ε) 253 (4.45), 328 (3.68), 359 (3.91) 
Mp (°C) 181–183 °C  
[α]22D +58 (c 0.2, MeOH) 
 
Malettinin E (4) was assigned a molecular formula of C16H20O5 based upon HRESIMS. 
The physico-chemical properties of 4 are summarized in Table III.2. The molecular 
formula of 4 being the same as for 2 and 3 suggested the compounds to be isomeric. In 
addition, the one- and two-dimensional NMR spectra of 4 (
1
H, 
13
C, DEPT, COSY, 
HSQC and HMBC; see Table III.3 and Supporting Information) revealed the presence 
of considerable structural similarities with 2 and 3 (Table III.4) (Angawi et al. 2005). 
The 
1
H and 
13
C NMR data of 4 showed resonances for three methyl, two methylene and 
two aliphatic methine groups, one oxygenated methine and one carbonyl group as well 
as signals for six aromatic carbons and one oxygenated quaternary carbon. Thus, all 
structural groups and atoms present in 2 or 3 were also observed for 4. Correlations of 
the aromatic protons in the HMBC NMR spectrum (Figure III.2) established the same 
tropolone moiety for 4 as found in the known malettinins. In addition to the tropolone 
unit, 4 contained a dihydropyran ring identical to that of 2 and 3. The proton and carbon 
chemical shifts of the corresponding signals were in good agreement with those 
reported for 2 and 3, with the proton signals agreeing particularly well to the structure 
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of 3. HMBC couplings from H2-7 to C-5, C-6 and C-15 gave evidence for the 
attachment of the dihydropyran ring to the tropolone moiety. The NMR data determined 
the remaining structural part of 4 to be a tetrahydrofuran ring connected to the 
dihydropyran unit via C-9 (Figure III.2). As a result, compound 4 was proven to have 
the same planar structure as described for 2 and 3. The vicinal JH7–H8 values of 4 (5.7 
and 10.3) showed better correlations with those of 3 (5.9 and 13) than with those of 2 
(6.2 and 3.8), suggesting a configuration like in 3 for the stereogenic center at C-9. 
However, the structures were not identical as considerable deviations in the chemical 
shifts of the proton and carbon signals of CH-12 (δH 2.23, δC 43.0) and CH-13 (δH 3.96, 
δC 86.0) in 4 were observed when compared to the reported shifts of the respective 
signals in 3 (δH 2.5, δC 34.7 and δH 4.32, δC 73.0, respectively) (Angawi et al. 2005). 
Taken the NMR data together, it seemed most likely that 4 was a stereoisomer of 
malettinin C (3), differing in the configuration at C-12 and/or C-13. 
Table III.3. 
1
H and 
13
C NMR spectroscopic data of malettinin E (4) (600 MHz and 
150 MHz) in methanol-d4. 
Position δC, Type δH, Mult. (J in Hz) COSY HMBC 
1 115.4, CH 6.92, s   2, 3, 6, 7, 15 
2 166.7, C 
   
3 173.0, C 
   
4 125.7, CH 7.13, s 16 2, 3, 5, 6, 15, 16 
5 152.0, C 
   
6 124.0, C 
   
7a   33.2, CH2 2.78, dd (17.5, 5.7) 7b, 8 5, 6, 8, 9, 15, 17 
7b 
 
2.51, dd (17.5, 10.3) 7a, 8 5, 6, 8, 9, 15, 17 
8   31.0, CH 2.25, m
a
 7a, 7b, 17 6, 7, 9, 17 
9 111.7, C 
   
11a   73.2, CH2 4.08, t (8.1) 11b, 12 9, 12, 13, 18 
11b 
 
3.62, t (9.2) 11a, 12 12, 13, 18 
12   43.0, CH 2.23, m
a
 11a, 11b, 13, 18 11, 13, 18 
13   86.0, CH 3.96, d (7.8) 12 8, 9, 11, 12, 18 
15 161.8, C 
   
16   27.2, CH3 2.41, s br 4 4, 5, 6, 7, 15 
17   15.8, CH3 1.143, d (6.5) 8 6, 7, 8, 9 
18   14.6, CH3 1.145, d (6.8) 12 11, 12,  13 
a
Signal deduced from the HSQC NMR spectrum. 
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Figure III.2. Selected HMBC (arrows) and 
COSY (bold) correlations for 4. 
 
 
 
 
 
Table III.4. 
13
C and 
1
H NMR spectroscopic data of malettinin B (2) and C (3) according to 
Angawi et al. (2005) and malettinin E (4). 
  Malettinin B (2)  
Malettinin C (3) 
 
Malettinin E (4) 
Position δC
a
 δH, Mult. (J in Hz)
b
   δC
c
 δH, Mult. (J in Hz)
b
   δC
d
 δH, Mult. (J in Hz)
d
 
1 112.6 6.76, s 
 
113.2 6.95, s 
 
115.4 6.92, s 
2 164.1 
  
164.4 
  
166.7 
 
3 173.0 
  
171.7 
  
173.0 
 
4 125.0 7.01, s 
 
125.0 7.06, s 
 
125.7 7.13, s 
5 151.2 
  
149.8 
  
152.0 
 
6 120.2 
  
122.2 
  
124.0 
 
7a 33.9 3.02, dd (17, 6.2) 
 
32.0 2.80, dd (17, 5.9) 
 
33.2 2.78, dd (17.5, 5.7) 
7b 
 
2.56, dd (17, 3.8) 
  
2.52, dd (17, 13) 
  
2.51, dd (17.5, 10.3) 
8 28.8 2.57, m 
 
29.9 2.22, m 
 
31.0 2.25, m 
9 113.1 
  
106.2 
  
111.7 
 
11a 74.5 4.18, t (7.8) 
 
73.7 4.12, dd (8.8, 7.7) 
 
73.2 4.08, t (8.1) 
11b 
 
3.64, dd (10, 7.8) 
  
3.65, dd (8.8, 5.8) 
  
3.62, t (9.2) 
12 36.8 2.70, m 
 
34.7 2.50, m 
 
43.0 2.23, m 
13 76.6 3.90, d (4.8) 
 
73.0 4.32, d (8.7) 
 
86.0 3.96, d (7.8) 
15 160.3 
  
158.3 
  
161.8 
 
16 27.2 2.36, s 
 
26.9 2.40, s 
 
27.2 2.41, s br 
17 14.3 1.01, d (6.6) 
 
15.0 1.08, d (6.6) 
 
15.8 1.143, d (6.5) 
18 10.3 1.04, d (6.6)   12.8 1.21, d (7.2)   14.6 1.145, d (6.8) 
a
Recorded in acetone-d6 at 90-100 MHz.
 b
Recorded in acetone-d6 at 400 MHz.
 c
Recorded in chloroform-d1 at 
90-100 MHz.
 d
Recorded in methanol-d4 at 600 MHz or 150 MHz, respectively. 
In order to determine the relative configuration of 4 conclusively, a single-crystal X-ray 
diffraction analysis was performed. It showed that the compound consisted of two 
crystallographically distinct molecules (4a and 4b) with identical relative configuration 
exhibiting slight conformational differences between the molecules (Figure III.3). The 
X-ray crystal structure of 4 confirmed the assumptions made on the basis of the NMR 
data as it was found to be identical to 3 except for the configuration at C-13. Thus, 4 
was identified to be the C-13 epimer of 3 as shown in Figure III.1. 
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Biological Activities 
Compounds 1–4 were tested for biological activities against a set of bacterial and fungal 
test strains. The malettinins were found to be bioactive against the plant pathogenic 
bacterium Xanthomonas campestris and the human pathogenic dermatophyte 
Trichophyton rubrum (Table III.5). Compounds 2–4 showed inhibition of X. campestris, 
whereas 1 did not inhibit the bacterial test strain notably. The IC50 values of 2–4 were in 
approximately the same concentration range (28.3-37.9 µM). With regard to T. rubrum, 
all tested malettinins 1–4 exhibited inhibitory activities. However, the strength of 
inhibition differed between the compounds, with the new malettinin (4) and 1 showing 
highest activities (IC50 of 30.7 and 33.1 µM), while 2 was half as active (IC50 of 60.6 
µM) and 3 was even less active (IC50 of 83.2 µM). 
Beside the reported antifungal and antibacterial properties in Table III.5, malettinins B 
and C (2 and 3) showed weak inhibition (<80%) of Staphylococcus epidermidis, 
Bacillus subtilis and Candida albicans at a test concentration of 100 µM. At the same 
concentration, malettinin E (4) exhibited weak inhibitory effects on the metabolic 
activity of S. epidermidis and C. albicans. Malettinin A did not show antibacterial 
effects, but also inhibited C. albicans (81% inhibition at 100 µM). As these activities 
were poor, IC50 values were not determined. 
Figure III.3. Crystal structures of the two crystallographically 
distinct molecules of malettinin E (4a and 4b). The H atoms of 
one of the methyl groups in 4b are disordered. 
4a 
4b 
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Table III.5. IC50 values for antibacterial and antifungal activities 
of malettinins A–C and E (1–4).  
Compound 
X. campestris         
IC50 [µM] 
T. rubrum              
IC50 [µM] 
Malettinin A (1) > 100 33.1 (±4.6) 
Malettinin B (2) 28.3 (±5.4) 60.6 (±2.3) 
Malettinin C (3) 37.9 (±3.8) 83.2 (±3.0) 
Malettinin E (4) 28.7 (±1.7) 30.7 (±0.2) 
Chloramphenicol 2.1 (± 0.6) ND 
Clotrimazole ND 0.2 (± 0.0) 
Abbreviation: ND, not determined. 
 
Discussion 
For the first time, malettinins A–C and E (1–4) were isolated from a fungus belonging 
to the genus Cladosporium. Originally, 1–3 were purified from an unidentified fungal 
colonist, which additionally produced a forth related metabolite called malettinin D 
(Angawi et al. 2003, Angawi et al. 2005). Malettinin D has not been detected in the 
culture extracts of Cladosporium sp. strain KF501, instead a new 13-epimer of 3, named 
malettinin E (4), was found to be produced. 1–4 are members of the family of tropolone 
fungal metabolites containing an α-tropolone substructure. Even though many 
derivatives possessing a partial structure of this tropolone type are described for plants, 
only few such compounds have been reported within the fungal kingdom. 
Representative structures of fungi are puberulic acid, puberulonic acid, stipitatic acid 
and related structures (Corbett et al. 1950, Iwatsuki et al. 2011). More complex known 
compounds are epolone A or B, pycnidione, eupenifeldin or fusariocin C (Ito et al. 
1981, Mayerl et al. 1993, Cai et al. 1998), which structurally share the fused 
tropolone/dihydropyran ring structure with the malettinins. However, malettinins 1–4 
are unique with regard to their linkage of the tropolone/dihydropyran ring to a furan.  
Malettinins A–C (1–3) were described as displaying weak inhibitory properties against 
C. albicans, B. subtilis and S. aureus employing disc diffusion assays (Angawi et al. 
2003, Angawi et al. 2005). In addition, 1 inhibited Aspergillus flavus and Fusarium 
verticillioides (Angawi et al. 2003). Even though the activities against C. albicans, B. 
subtilis and antistaphylococcal activities against S. epidermidis were observed for 2 and 
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3 in this study as well, higher activities were found when profiled against the bacterium 
X. campestris and the fungus T. rubrum. X. campestris causes a variety of plant 
diseases, e.g., black rot in cabbage which is difficult to treat and therefore leads to high 
crop losses (Roohie and Umesha 2012). T. rubrum is responsible for clinical pictures 
like tinea pedis (athlete’s foot) and likewise treatments are challenging, in part due to 
the toxicity in long-term treatments (Ramsey et al. 2013). New bioactive compounds for 
better treatments in plant protection as well as in clinical aspects are hence highly 
desirable. Comparing activities though shows that the malettinins inhibit X. campestris 
with a 13-fold higher IC50 than the antibiotic chloramphenicol used as positive control. 
Thus, their activities can be considered as moderate, only. The inhibition of the 
malettinins against T. rubrum is rather poor given that the IC50 of the positive control 
clotrimazole is lower by a factor of greater than 170.  
The activities regarding X. campestris showed that all stereoisomeric compounds (2–4) 
inhibited the test strain in comparable concentration ranges, while 1, possessing a very 
slightly varied furan ring, did not show inhibition. This observation suggests that the 
furan ring of the malettinins is critical for antibacterial properties against X. campestris. 
With regard to activities against T. rubrum, apparently configurational changes of the 
malettinins determine the strength of activity, since the distinct stereoisomers exhibited 
different IC50 values.  
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GENERAL DISCUSSION 
Natural products isolated from fungi have proved very valuable for mankind, owing to 
their use, e.g., in medicine and agriculture. However, the low-hanging fruits in natural 
product discovery have been picked and it becomes an increasingly difficult 
undertaking to find new bioactive compounds. Lower hit rates and the re-discovery of 
known compounds, amongst others, drive up the costs for the discovery and 
development of drugs derived from natural products. Pharmaceutical companies have 
thus changed their strategic orientation und turned their focus to combinatorial 
chemistry. With the synthesis of new organic compounds by the combination of a set of 
smaller chemical structures, libraries comprising millions of compounds can be 
generated within a short time and are screened for bioactivities in high-throughput 
screenings. Yet the success of this method has not materialized to date as only one de 
novo drug (sorafenib) has emerged from synthetic-combinatorial libraries in the last 30 
years (Newman and Cragg 2012). Thus, in comparison, 0.001% of compounds 
synthesized by combinatorial chemistry became accepted drugs, while of the known 
microbial metabolites about 0.2–0.3% became a therapeutic product and about the same 
number served as lead compounds for the development of new drugs. Therefore, 
microbial natural products show a more than two order of magnitude higher efficacy 
than compounds originating from combinatorial chemistry (Bérdy 2005). These figures 
paired with the increasing resistances toward current drugs and newly emerging 
pathogens demand concerted efforts in the drug discovery from natural products.  
The aim of the present PhD thesis was thus to find new fungal natural products by 
creating a screening strategy that allows picking the “high-hanging fruits”. For this 
purpose, different approaches approved for natural product discovery were combined 
(fungal isolates from little-explored ecosystems, less studied genera, genetic potential 
according to PKS and NRPS gene sequences and stimulating effects on biosynthesis by 
variation of culture conditions) and used for a rational selection of fungi which were in 
detail investigated with regard to their biosynthesized natural products. In this way, 
three new cyclodepsipeptides, five new linear and macrocyclic polyesters and one new 
tropolone structure were identified and characterized. Given that as a general rule up to 
10,000 microbial extracts need to be analyzed to discover one to ten new bioactive 
structures (Gräfe 1999), the respective ratio in the studies presented here is impressively 
high. From only 243 extracts, nine new natural products including five active 
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compounds were described, proving the screening strategy employed very effective. In 
addition, even if taking into account that some of the nine compounds are structurally 
related, the number of three different structural classes isolated by a screening of 243 
extracts still presents a fairly good ratio.  
Unlike other organisms, microbes colonize all living and non-living niches on Earth 
such as arctic, antarctic and alpine regions, deserts, deep rock sediments and marine 
environments including the Wadden Sea (Gunatilaka 2006). According to literature, it is 
for the first time that fungal natural products isolated from Wadden Sea waters were 
described. However, such a literature survey might not totally depict the situation as 
examples are known where the isolation site was not specified to the Wadden Sea, but 
the North Sea in general (Schulz et al. 2011). As had been demonstrated for bacteria 
before (Liang 2003, Bitzer et al. 2006, Grossart et al. 2009), it was shown that fungal 
strains originating from the Wadden Sea possess the potential to produce a diverse 
range of natural products. Notably, the fungi were isolated from water samples, which 
usually are not a frequent source for strains reported to produce new natural products 
(Figure 4). Approximately two-thirds of all new compounds produced by marine-
derived fungi originate from strains isolated from plant and animal sources. Concerning 
the non-living sources, sediments form the largest segment, while fungi derived from 
water samples only account for 1% of newly characterized natural products (Rateb and 
Ebel 2011). 
 
 
 
 
 
 
 
 
 
Figure 4. New compounds from marine-derived fungi until mid-
2010, divided by sources of the producing strains (according to 
Rateb and Ebel 2011). 
GENERAL DISCUSSION                                                                                                                                                                               78 
Though isolated from the Wadden Sea, it remains unclear whether the fungal isolates 
investigated in the studies were obligate or facultative marine organisms or if they were 
isolated as dormant spores from the water. The Wadden Sea as a land/ocean interface, 
of course, receives input of terrestrial and freshwater fungi, for instance, by river inflow 
or via air (especially important for fungal spores). According to Kohlmeyer and 
Kohlmeyer (1979), obligate marine fungi are those that grow and sporulate exclusively 
in a marine or estuarine habitat, whereas facultative marine fungi are those from 
freshwater or terrestrial areas able to grow (and possibly also to sporulate) in the marine 
environment. The fungal isolates described in chapters I–III could be facultative marine 
organisms as they grew on modified casamino acids glucose medium not containing 
sodium chloride as well as on modified Wickerham medium with sodium chloride 
supplemented. Nevertheless, Calcarisporium and Cladosporium strains belong to 
ubiquitous genera common to terrestrial habitats and no definite statement can be made 
unless actual growth in sea water is tested (Shearer et al. 2007). 
Furthermore, the results of the study show that it is worth to have a look for novel 
natural products in less studied fungal genera. However, with only two strains, namely a 
Calcarisporium sp. and a Cladosporium sp., it is a small number of organisms that 
produced new natural products. In this regard, the fact that the initial collection of 
fungal isolates lacked high diversity is considered an important reason. Even though the 
total number of strains screened was large (109 strains), 30 isolates belonged to the 
particularly well-investigated genus Penicillium and another 30 isolates were yeasts 
which rarely produce bioactive compounds (Bérdy 2005). The search for new natural 
products in not extensively investigated genera is a screening approach that is 
presumably more promising when applied to a more diverse group of fungal isolates. 
Therefore, the isolation procedure is of crucial importance, requiring the employment of 
various different isolation techniques. In addition, the selection of fungi from 
biodiversity “hotspots” such as mangrove habitats (Shearer et al. 2007) or from 
sponges, which are supposed to host unique and diverse fungal communities (Bugni and 
Ireland 2004, Wang 2006, Wiese et al. 2011), as an additional criterion for the screening 
would probably enhance the screening output.  
While microbial natural product discovery for decades was a rather coincidence-driven 
culturing and screening of thousands of strains, the advances in genome sequencing 
offer more directed possibilities. Schneemann (2011) showed for actinomycetes that 
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strains selected based on the presence of biosynthetic genes for natural products 
according to molecular biological analysis produced higher numbers and more diverse 
natural products as compared to strains where no such biosynthetic genes were 
detectable. Similarly, a genetic screening for PKS and NRPS genes in the fungal 
isolates of this study was performed and proved a fast and useful tool to prioritize 
strains with the genetic capabilities to produce natural products. The increasing number 
of fungal genome sequencing data indicates that when a strain harbors one gene cluster 
for the biosynthesis of natural products, it is likely that further gene clusters are also 
present (Keller et al. 2005, Khaldi et al. 2010, Brakhage and Schroeckh 2011). Thus, a 
positive screening for PKS or NRPS genes can help to find interesting producing 
organisms. Nonetheless, it has also become clear that identifying the biosynthetic genes 
and pathways is much easier than finding the associated natural products (Jensen et al. 
2013). Genomics-based investigation of natural product biosynthesis revealed that an 
even greater number of gene clusters stay silent in the laboratory than formerly thought 
(Hertweck 2009). This means that despite having access to microbial genomes 
nowadays, the induction of expression of the numerously proven gene clusters still 
represents one of the major bottlenecks in the research field and the process of natural 
product discovery therefore largely remains a matter of serendipity (Jensen et al. 2013). 
Various approaches can be followed to activate the silent gene clusters. Here, their 
expression was stimulated by the variation of the culture media as becomes obvious by 
the fact that all new compounds were isolated from cultures in casamino acids glucose 
medium, but not from the initial standard cultures (modified Wickerham medium). The 
approach offers infinite possibilities for continuation, e.g., the creation of culture media 
that mimic the natural parameters of the original habitat or the employment of 
epigenetic modifiers. Equivalently, alternative strategies for the activation of 
biosynthetic pathways, in particular by means of molecular genetic manipulation, exist. 
Especially for Calcarisporium sp. strain KF525 further investigations should be taken 
into consideration, because the strain produces compounds of different structural classes 
and may hence well have the potential to synthesize an even greater variety of natural 
products. First steps toward this direction have been undertaken as the genome of 
KF525 was sequenced and is currently evaluated with regard to biosynthetic gene 
clusters for natural products (unpublished data). 
In addition, the genome sequence data of KF525 form the basis for future analysis on 
the biosynthetic mechanisms involved in the calcaripeptide production. According to 
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the biosynthetic studies performed, the calcaripeptides presumably belong to the 
structural class of PKS−NRPS hybrids. PKS−NRPS hybrid molecules were discovered 
in fungi only a decade ago and the programming of hybrid synthetases is much less 
understood than in bacteria. To date, approximately a dozen PKS−NRPS 
megasynthetases can be linked to the corresponding natural products (Boettger and 
Hertweck 2013). Typically, these hybrid enzymes consist of a type I iterative PKS 
module, which is followed by a single NRPS module fusing the polyketide chain to one 
amino acid (Fisch 2013). Two possible release mechanisms are currently discussed 
involving either a Dieckmann cyclization or a reductive release to form a free aldehyde 
that can undergo a Knoevenagel condensation (Figure 5) (Boettger and Hertweck 2013). 
As a result, the primary products of PKS−NRPS hybrid synthetases are acyltetramic 
acids, which can further be altered by additional enzymes to yield the final hybrid 
compound (Molnár et al. 2010).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Remarkably, the calcaripeptides differ from this prototype of PKS−NRPS hybrids. First 
of all, they contain two amino acid moieties and second, showing no tetramic acid 
Figure 5. Possible release mechanisms of PKS− 
NRPS hybrids to yield tetramic acids (black) 
and pyrrolinones (gray) (according to Boettger 
and Hertweck 2013). 
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structural nature, a Dieckmann cyclisation or Knoevenagel condensation during 
biosynthesis is unlikely. For the emericellamides which similarly contain more than one 
amino acid residue and are no tetramic acid derivatives, a biosynthetic route involving 
two distinct enzymes (one PKS and one NRPS) was described (Chiang et al. 2008). The 
exact release and cyclization mechanism in the formation of the emericellamides 
remains to be elucidated though, as the involved NRPS enzyme does not contain a TE-
domain (Chiang et al. 2008). In fact, several other PKS−NRPS hybrids that are no 
derivatives of tetramic acid and contain one or more amino acids have been observed in 
fungi, but their biosynthesis is not understood (Ratnayake et al. 2008, Pittayakhajonwut 
et al. 2009, Vervoort et al. 2011, Guo et al. 2012, Krasnoff et al. 2012). By taking 
advantage of the genomic DNA data of strain KF525, the identification of the gene 
cluster encoding the calcaripeptide biosynthetic enzymes will hence not only bring light 
into their biosynthetic machinery, but more importantly also improve the general 
understanding of PKS−NRPS hybrid biosynthesis in fungi.  
With respect to the application potential of the new compounds, malettinin E and the 
calcarides exhibited antibacterial and antifungal bioactivities against test strains relevant 
for human and plant diseases. Though moderately active in their natural forms, it 
remains to be evaluated if they have a potential as drugs and agrochemicals in a 
chemically modified form. Interesting bioactive properties of natural products are often 
not detected at first sight, as it is the case for the calcaripeptides. Despite their 
presumable role in specific biological interactions on the basis of bioactivities in the 
natural environment, only close to 50% of all known microbial metabolites display 
some kind of biological activity in laboratory experimental set-ups (Bérdy 2012). Given 
that the calcaripeptides have a high structural novelty, it could well be that the 
compounds possess unique bioactive properties. In order to find these, a testing of a 
broader range of targets is required. Found bioactive properties would then be all the 
more interesting as the so far performed assays support a specific activity profile for the 
calcaripeptides and many side effects, e.g., of cytotoxic nature, can most likely be ruled 
out already by now.  
Certainly, the way from the first discovery of a new compound to an approved drug is 
long. The most advanced natural product of a marine-derived fungus in the drug 
pipeline is the diketopiperazine halimide discovered by Fenical et al. (1998) in the 
1990s. The cytotoxic compound was isolated from an Aspergillus sp. collected in the 
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waters off the Philippine Islands. Halimide served as a lead structure for the closely 
related synthetic analog plinabulin which is currently undergoing phase II clinical trials 
in combination with docetaxel in patients with advanced non-small cell lung cancer 
(ClinicalTrials.gov 2013, Rateb and Ebel 2011). This example and the more than 1000 
new natural products from marine-derived fungi point out the important role of this 
group of organisms for drug discovery (Rateb and Ebel 2011). Furthermore, the studies 
presented here clearly show that the potential for natural product biosynthesis in fungi 
from marine habitats is far from being exploited. To say it with Newman and Cragg 
(2012), “Much of Nature’s treasure trove of small molecules remains to be explored, 
particularly from the marine and microbial environments”.  
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APPENDIX 
Supporting Information for Chapter I 
AI.1. 
1
H NMR (600 MHz, methanol-d4) spectrum of calcaripeptide A (1). 
 
 
AI.2. COSY (600 MHz, methanol-d4) spectrum of calcaripeptide A (1). 
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AI.3. 
13
C NMR (150 MHz, methanol-d4) spectrum of calcaripeptide A (1). 
 
 
AI.4. HSQC (600 MHz, methanol-d4) spectrum of calcaripeptide A (1). 
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AI.5. HMBC (600 MHz, methanol-d4) spectrum of calcaripeptide A (1). 
 
 
AI.6. NOESY (500 MHz, methanol-d4) spectrum of calcaripeptide A (1). 
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AI.7. 
1
H NMR (500 MHz, acetone-d6) spectrum of calcaripeptide B (2). 
 
 
AI.8. 
13
C NMR (125 MHz, acetone-d6) spectrum of calcaripeptide B (2). 
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AI.9. 
1
H (500 MHz) and 
13
C (125 MHz) NMR spectroscopic data of calcaripeptide B 
(2) in acetone-d6. 
Position δC, Type δH, Mult. (J in Hz) COSY HMBC 
1 167.5, C       
2a   48.2, CH2
a
 4.32, br s 2b 1, 3 
2b  3.15, br s 2a 1,3, 4 
3 196.3, C    
4 136.0, C    
5 149.4, CH 6.40, br d (10.1) 6, 4-CH3 3, 6, 7, 4-CH3, 6-CH3 
6   34.6, CH 2.53, m 5, 7a, 7b, 6-CH3 4, 7, 8, 6-CH3 
7a   35.4, CH2 1.44, m
b
 6, 7b, 8a, 8b 5, 6, 8, 9, 6-CH3 
7b  1.15, m 6, 7a, 8a, 8b 5, 6, 8, 9 
8a   35.6, CH2 1.48, m
b
 7a, 7b, 8b, 9 6, 7, 9, 9-CH3 
8b  1.32, m 7a, 7b, 8a, 9 6, 7, 9-CH3 
9   74.1, CH 4.63, m 8a, 8b, 9-CH3 8 
4-CH3   11.6, CH3 1.70, d (1.3) 5 3, 4, 5, 6, 7, 6-CH3 
6-CH3   20.6, CH3 0.98, d (6.6) 6 5, 6, 7 
9-CH3   20.9, CH3 1.18, d (6.2) 9 8, 9 
1' 171.2, C    
2'   59.7, CH 3.85, br d (7.5) 3a', 3b' 1', 3', 4', 5' 
3a'   29.0, CH2 2.01
c
 2', 3b', 4' 1', 4', 5' 
3b'  1.29, m 2', 3a', 4' 1', 2', 4' 
4'   22.5, CH2 1.77, m 3a', 3b', 5a', 5b' 2', 3', 5' 
5a'   46.2, CH2 3.39, m 4', 5b' 2', 3', 4', 1'' 
5b'  3.34, m 4', 5a' 2', 3', 4', 1'' 
1'' 170.6, C    
2''   53.4, CH 5.18, m 3a'', 3b'', NH-2'' 1, 1'', 3'', 4'' 
3a''   41.2, CH2 3.08, dd (12.8, 5.0) 2'', 3b'', 5'' + 9'' 1'', 2'', 4'', 5'' + 9'' 
3b''  2.80, dd (12.8, 9.0) 2'', 3a'', 5'' + 9'' 1'', 2'', 4'', 5'' + 9'' 
4'' 137.7, C    
5'' + 9'' 130.3, CH 7.20, br d (8.4) 3a'', 3b'', 6'' + 8'' 3'', 5'' + 9'', 6'' + 8'', 7'' 
6'' + 8'' 129.3, CH 7.31, br dd (8.4, 7.4) 5'' + 9'', 7'' 4'', 5'' + 9'', 6'' + 8'', 7'' 
7'' 127.7, CH 7.24, br t (7.4) 6'' + 8'' 4'', 5'' + 9'' 
NH-2''  7.51, br d (6.7) 2''  
a
Signal deduced from the HSQC spectrum. 
b
Proton signals of 7a and 8a overlap. 
c
Signal partially 
obscured.  
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AI.10. 
1
H NMR (600 MHz, acetone-d6) spectrum of calcaripeptide C (3). 
 
 
 
AI.11. 
13
C NMR (150 MHz, acetone-d6) spectrum of calcaripeptide C (3). 
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AI.12. 
1
H (600 MHz) and 
13
C (150 MHz) NMR spectroscopic data of calcaripeptide C 
(3) in acetone-d6. 
Position δC, Type δH, Mult. (J in Hz) COSY HMBC 
1 171.0, C       
2   52.3, CH 3.66, q (6.9) 2-CH3 1, 3, 4, 2-CH3 
3 209.3, C    
4   44.1, CH 2.85, m 5a, 5b, 4-CH3 3, 5, 6, 4-CH3 
5a   31.8, CH2 1.53, m
a
 4, 5b, 6a, 6b 3, 4, 6, 7, 4-CH3 
5b  1.06, m 4, 5a, 6a, 6b 3, 4, 6, 7, 4-CH3 
6a   35.3, CH2 1.67, m 5a, 5b, 6b, 7 3, 4, 5, 7, 4-CH3, 7-CH3 
6b  1.53, m
a
 5a, 5b, 6a, 7 3, 4, 5, 7, 4-CH3, 7-CH3 
7   74.0, CH 4.84, m 5b, 6a, 6b, 7-CH3 4, 5, 6, 4-CH3, 7-CH3, 1' 
2-CH3   14.5, CH3 1.22, d (6.9) 2 1, 2, 3 
4-CH3   15.6, CH3 1.02, d (6.7) 4 3, 4, 5 
7-CH3   21.0, CH3 1.19, d (6.3) 7 6, 7 
1' 172.2, C    
2'   59.8, CH 3.90, m 3a', 3b' 1', 3', 4', 5', 1'' 
3a'   30.3, CH2 1.87, m 2', 3b', 4b', 5' 1', 2', 4', 5', 1'' 
3b'  1.46, m 2', 3a', 4b', 4a', 5' 1', 2', 4', 5' 
4a'   22.4, CH2 1.88, m 3b', 4b', 5' 1', 2', 3', 5' 
4b'  1.71, m 3a', 3b', 4a', 5' 1', 2', 3', 5' 
5'   46.3, CH2 3.38, m 3a', 3b', 4a', 4b' 2', 3', 4', 1'' 
1'' 169.6, C    
2''   54.2, CH 4.97, m 3a'', 3b'', NH-2'' 1, 1'', 3'', 4'' 
3a''   40.6, CH2 3.06, ddt (12.5, 4.7, 2.5) 2'', 3b'' 1'', 2'', 4'', 5'' + 9'' 
3b''  2.93, dddd (12.5, 10.0, 
3.2, 2.1) 
2'', 3a'' 1'', 2'', 4'', 5'' + 9'' 
4'' 138.2, C    
5'' + 9'' 130.2, CH 7.25, br d (7.5) 6'' + 8'' 2'', 3'', 4'', 5'' + 9'', 6'' + 8'', 7'' 
6'' + 8'' 129.2, CH 7.30, br t (7.5) 5'' + 9'', 7'' 3'', 4'', 5'' + 9'', 6'' + 8'', 7'' 
7'' 127.5, CH 7.23, br t (7.5) 6'' + 8'' 4'', 5'' + 9'', 6'' + 8'' 
NH-2''  7.61, br d (7.5) 2''  1, 1'', 2'' 
a
Proton signals of 5a and 6b overlap. 
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AI.13. Feeding experiment with 1-
13
C-acetate:  
13
C NMR (125 MHz, methanol-d4) spectrum of calcaripeptide A (1).  
 
 
Calculation of 
13
C enrichment 
13
C enrichment in calcaripeptide A (1) was calculated according to Scott et al. (1974). J. 
Am. Chem. Soc. 96(26), 8069-8080: 
Enrichment  = 1.1% × 
integrated intensity I [labeled] 
- 1.1% 
integrated intensity I [unlabeled] 
 
Position I [labeled] I [unlabeled] Enrichment [%] 
1 1.92 0.45 3.6 
3 1.80 0.45 3.3 
5 4.00 0.89 3.8 
7 4.41 1.17 3.0 
9 4.07 1.03 3.2 
1’ 0.99 0.44 1.4 
5’ 2.68 1.14 1.5 
For comparison of integrated intensities the integral of the signal of C-2’                                                          
was set to 1.00000 in the spectra of both labeled and unlabeled 1. 
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AI.14. Feeding experiment with L-methionine-methyl-
13
C:  
13
C NMR (150 MHz, methanol-d4) spectrum of calcaripeptide A (1). 
 
 
Calculation of 
13
C enrichment 
13
C enrichment in calcaripeptide A (1) was calculated according to Scott et al. (1974). J. 
Am. Chem. Soc. 96(26), 8069-8080: 
Enrichment  = 1.1% × 
integrated intensity I [labeled] 
- 1.1% 
integrated intensity I [unlabeled] 
 
Position I [labeled] I [unlabeled] Enrichment [%] 
2-CH3 67.78 1.15 63.7 
4-CH3 57.60 1.00 62.3 
6-CH3 67.17 1.20 60.5 
For comparison of integrated intensities the integral of the signal of C-2’                                                          
was set to 1.00000 in the spectra of both labeled and unlabeled 1. 
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AI.15. Activity assays - test strains, cell lines and enzymes. 
Calcaripeptides A–C (1-3) were tested for antibacterial, antifungal and cytotoxic 
properties and for inhibition of selected enzyme targets. The tested strains, cell lines and 
enzymes were as follows (compound concentration in assay): Bacillus subtilis DSM 347 
(100 µM), Staphylococcus lentus DSM 6672 (100 µM), Staphylococcus epidermidis 
DSM 20044 (100 µM), Xanthomonas campestris DSM 2405 (100 µM), 
Propionibacterium acnes DSM 1897 (100 µM), Candida albicans DSM 1386 (100 
µM), Septoria tritici (100 µM), Phytophthora infestans (50 µM), Trichophyton rubrum 
(100 µM), HepG2 cell line (50 µM), KIF5 fibroblasts (50 µM), glycogen synthase 
kinase-3β (10 µM), acetylcholinesterase (10 µM), phosphodiesterase 4B2 (10 µM) and 
protein tyrosine phosphatase 1B (10 µM). Moreover, calcaripeptide A (1) was tested 
negative for activities against Ralstonia solanacearum DSM 9544 (100 µM), in enzyme 
assays for reverse transcriptase (10 µM), histone deacetylase 6 (100 µM), histone 
deacetylase 8 (100 µM) and against the cell lines 786-0, MCF-7, M14, HL-60(TB), 
CCRF-CEM, K-562, MOLT-4, SR, A549/ATCC, COLO 205, HT29, KM12, SW-620, 
SF-268, SF-539, SK-MEL-5, OVCAR-3, OVCAR-8, NCI/ADR-RES, SK-OV-3, PC-3, 
T-47D as well as HEK-293 and PBMC (50 µM in all cell lines). 
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Supporting Information for Chapter II 
AII.1. 
1
H NMR (500 MHz, acetone-d6) spectrum of calcaride A (6). 
 
 
AII.2. 
13
C NMR (500 MHz, acetone-d6) spectrum of calcaride A (6). 
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AII.3. COSY (500 MHz, acetone-d6) spectrum of calcaride A (6). 
 
 
AII.4. HSQC (500 MHz, acetone-d6) spectrum of calcaride A (6). 
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AII.5. HMBC (500 MHz, acetone-d6) spectrum of calcaride A (6). 
 
 
AII.6. 
1
H NMR (500 MHz, methanol-d4) spectrum of calcaride B (7). 
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AII.7. NMR spectroscopic data (500 MHz, methanol-d4) of calcaride B (7). 
Position δC, Type δH, Mult. (J in Hz) COSY HMBC 
1   171.5, C
a
 
   
2a     41.0, CH2 2.88, dd (7.7, 16.6) 2b, 3 1, 3, 4, 5 
2b 
 
2.73, d (5.3, 16.6) 2a, 3 1, 3, 4, 5 
3     70.2, CH 5.56, m 2a, 2b, 4 2, 4, 5 
4     20.2, CH3 1.42, d (6.3) 3 2, 3 
5 171.13, C 
   
6   108.7, C 
   
7   164.6, C 
   
8   100.7, CH 6.30, d (2.6) 10 5, 6, 7, 10 
9   164.9, C 
   
OCH3     55.8, CH3 3.75, s  
9 
10   111.5, CH 6.36, d (2.6) 8 5, 6, 8, 9, 12 
11   142.6, C 
   
12a     41.8, CH2 3.34
b
 12b, 13 6, 10, 11, 13, 14 
12b 
 
2.96, dd (6.4, 13.8) 12a, 13 6, 10, 11, 13, 14 
13     73.6, CH 5.07, m 12a, 12b, 14 11, 12, 14, 15 
14     20.0, CH3 1.20, d (6.2) 13 12, 13 
15 171.37, C
a
 
   
16a     41.6, CH2 2.81, dd (7.6, 15.8) 16b, 17 15, 17, 18 
16b 
 
2.67, dd (5.7, 15.8) 16a, 17 15, 17, 18 
17     70.4, CH 5.49, m 16a, 16b, 18 16, 18, 19 
18     20.2, CH3 1.40, d (6.4) 17 16, 17 
19 171.07, C 
   
20   106.7, C 
   
21   165.4, C 
   
22   102.8, CH 6.22, s 
 
19, 20, 21, 23, 24, 26 
23   163.5, C 
   
24   113.3, CH 6.22, s 
 
19, 20, 21, 22, 23, 26, 27 
25   143.2, C 
   
26a     42.3, CH2 3.32
b
 26b, 27 20, 24, 25, 27, 28 
26b 
 
2.77, dd (8.1, 13.3) 26a, 27 20, 24, 25, 27, 28 
27     73.5, CH 4.98, m 26a, 26b, 28 25, 26, 29 
28     19.5, CH3 1.11, d (6.2) 27 26, 27 
29 171.43, C
a
 
   
30a     36.7, CH2 2.68, dd (5.1, 16.7) 30b, 31 29, 31, 32 
30b 
 
2.64, dd (8.1, 16.7) 30a, 31 29, 31, 32 
31     72.7, CH 5.28, m 30a, 30b, 32a, 32b 1, 29, 30 
32a     63.6, CH2 3.65, dd (4.5, 11.9) 31, 32b 30, 31 
32b   3.58, dd (5.1, 11.9) 31, 32a 30, 31 
a
Assignments of C-1, C-15 and C-29 are interchangeable. 
b
Signal partially obscured and deduced from 
the HMBC NMR. 
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AII.8. 
1
H NMR (500 MHz, methanol-d4) spectrum of calcaride C (8). 
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AII.9. NMR spectroscopic data (500 MHz, methanol-d4) of calcaride C (8). 
Position δC, Type δH, Mult. (J in Hz) COSY HMBC 
1   171.6, C 
   
2a     41.2, CH2 2.878, dd (8.1, 16.2) 2b, 3 1, 3, 4 
2b 
 
2.79, dd (4.8, 16.2) 2a, 3 1, 3, 4 
3     70.5, CH 5.59, m 2a, 2b, 4 2, 4, 5 
4     20.2, CH3 1.44, d (6.4) 3 2, 3 
5 171.53, C
a
 
   
6   108.2, C 
   
7 165.08, C
a
 
   
8   100.7, CH 6.31, d (2.6) 10 5, 6, 7, 9, 10, 12 
9   165.0, C
a
 
   
OCH3
b
     55.8, CH3 3.74, s  
9 (or 7) 
10   111.3, CH 6.35, d (2.6) 8 5, 6, 7, 8, 9, 12 
11   142.7, C 
   
12a     41.7, CH2 3.35
c
 12b, 13 6, 10, 11, 13, 14 
12b 
 
2.99, dd (6.6, 14.0) 12a, 13 6, 10, 11, 13, 14 
13     73.2, CH 5.16, m 12a, 12b, 14 11, 12, 14, 15 
14     20.0, CH3 1.22, d (6.2) 13 12, 13 
15   171.3, C
a
 
   
16a     41.6, CH2
a
 2.85, dd (6.6, 16.0) 16b, 17 15, 17, 18 
16b 
 
2.69, dd (6.6, 16.0) 16a, 17 15, 17, 18 
17     70.3, CH 5.48, m 16a, 16b, 18 16, 18, 19 
18     20.1, CH3 1.39, d (6.3) 17 16, 17 
19 171.48, C
a
 
   
20   107.3, C 
   
21  165.14,C
a
 
   
22   102.7, CH 6.21, d (2.5) 
 
19, 20, 21, 23, 24, 26 
23   163.4, C 
   
24   112.6, CH 6.23, d (2.5) 
 
19, 20, 21, 22, 23, 26 
25   143.1, C 
   
26a     41.5, CH2
a
 3.31
c
 26b, 27 20, 24, 25, 27, 28 
26b 
 
2.885, dd (6.9, 13.4) 26a, 27 20, 24, 25, 27, 28 
27     73.6, CH 5.03, m 26a, 26b, 28 25, 26, 28, 29 
28     19.8, CH3 1.16, d (6.2) 27 26, 27 
29   171.9, C 
   
30a     40.4, CH2 2.51, dd (6.0, 15.3) 30b, 31 29, 31, 32 
30b 
 
2.43, dd (7.2, 15.3) 30a, 31 29, 31, 32 
31     67.1, CH 4.17, m 30a, 30b, 32a, 32b 29, 30, 32 
32a     68.5, CH2 4.12, dd (4.8, 11.1) 31, 32b 1, 30, 31 
32b   4.08, dd (5.5, 11.1) 31, 32a 1, 30, 31 
a
Assignments of C-5, C-15 and C-19, C-7 and C-21, C-7 and C-9, C-16 and C-26, respectively are 
interchangeable. 
b
Position of the methoxy group could not unambiguously be determined. In analogy to 
the other calcarides it was assumed to be linked to C-9. 
c
Signal partially obscured. 
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AII.10. 
1
H NMR (500 MHz, methanol-d4) spectrum of calcaride D (9). 
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AII.11. NMR spectroscopic data (500 MHz, methanol-d4) of calcaride D (9). 
Position δC, Type δH, Mult. (J in Hz) COSY HMBC 
1 173.9, C
a
 
   
2a   41.8, CH2 2.767, dd (7.5, 15.8) 2b, 3 1, 3, 4 
2b 
 
2.69, dd (5.3, 15.8) 2a, 3 1, 3, 4 
3   70.8, CH 5.57, m 2a, 2b, 4 1, 2, 4, 5 
4   20.1, CH3 1.43, d (6.4) 3 2, 3 
5 171.5, C
b
 
   
6 107.2, C 
   
7 166.0, C
b
 
   
8 100.8, CH 6.33, s 
 
5, 6, 7, 9, 10 
9 165.0, C
b
 
   
OCH3   55.9, CH3 3.77, s  
9 
10 112.8, CH 6.33, s 
 
5, 6, 7, 8, 9, 12, 13 
11 143.2, C 
   
12a   43.2, CH2 3.29
c
 12b, 13 6, 10, 11, 13, 14 
12b 
 
2.91, dd (9.7, 13.7) 12a, 13 6, 10, 11, 13, 14 
13   73.1, CH 5.22, m 12a, 12b, 14 11, 12, 14, 15 
14 20.52, CH3 1.25, d (6.2) 13 11, 12, 13 
15 171.2, C 
   
16a   41.8, CH2 2.66, dd (7.2, 15.7) 16b, 17 15, 17, 18 
16b 
 
2.62, dd (5.8, 15.7) 16a, 17 15, 17, 18 
17   70.0, CH 5.47, m 16a, 16b, 18 16, 18, 19 
18   19.9, CH3  1.30, d (6.4) 17 15, 16, 17 
19 171.6, C
b
 
   
20 105.8, C 
   
21 166.2, C 
   
22 102.7, CH 6.203, d (2.6) 
 
20, 21, 23, 24 
23 163.5, C 
   
24 113.8, CH 6.197, d (2.6) 
 
19, 20, 21, 22, 23, 26, 27 
25 143.7, C 
   
26a   43.5, CH2 3.17, dd (4.0, 13.4) 26b, 27 20, 24, 25, 27, 28 
26b 
 
2.772, dd (9.2, 13.4) 26a, 27 20, 24, 25, 27, 28 
27   72.7, CH 5.15, m 26a, 26b, 28 25, 26, 28, 29 
28 20.49, CH3 1.23, d (6.2) 27 25, 26, 27 
29 172.7, C 
   
30a   39.9, CH2 2.47, dd (5.2, 15.4) 30b, 31 29, 31, 32 
30b 
 
2.27, dd (7.9, 15.4) 30a, 31 29, 31, 32 
31   69.9, CH 3.94, m 30a, 30b, 32a, 32b 29, 30, 32 
32a   66.4, CH2 3.44, dd (4.9, 11.2) 31, 32b 30, 31 
32b   3.40, dd (5.7, 11.2) 31, 32a 30, 31 
a
Signal deduced from the HMBC NMR spectrum. 
b
Assignments of C-5 and C-19, C-7 and C-9, 
respectively are interchangeable.
 c
Signal partially obscured and deduced from the HSQC NMR 
spectrum. 
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AII.12. 
1
H NMR (600 MHz, methanol-d4) spectrum of calcaride E (10). 
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AII.13. NMR spectroscopic data (600 MHz, methanol-d4) of calcaride E (10). 
Position δC, Type δH, Mult. (J in Hz) COSY HMBC 
1   175.9, C
a
 
   
2a     43.3, CH2 2.72, dd (7.8, 15.4) 2b, 3 1, 3, 4 
2b 
 
2.61, dd (5.9, 15.4)
b
 2a, 3 1, 3, 4 
3     71.5, CH 5.58, m 2a, 2b, 4 1, 2, 4, 5 
4     20.3, CH3 1.43, d (6.3) 3 2, 3 
5 171.56, C
c
 
   
6   107.3, C 
   
7   166.0, C
c
 
   
8   100.8, CH 6.33, s 
 
5, 6, 7, 9, 10 
9   165.0, C
c
 
   
OCH3     55.9, CH3 3.77, s  
9 
10   112.8, CH 6.33, s 
 
5, 6, 7, 8, 9, 12, 13 
11   143.3, C 
   
12a     43.4, CH2 3.35, dd (3.5, 13.6)
b
 12b, 13 6, 10, 11, 13 
12b 
 
2.87, dd (9.8, 13.6) 12a, 13 6, 10, 11, 13, 14 
13     73.2, CH 5.22, m 12a, 12b, 14 11, 15 
14     20.6, CH3 1.26, d (6.3) 13 11, 12, 13 
15   171.2, C 
   
16a     41.8, CH2 2.65, dd (7.2, 15.6) 16b, 17 15, 17, 18 
16b 
 
2.62, dd (6.0, 15.6) 16a, 17 15, 17, 18 
17     70.0, CH 5.47, m 16a, 16b, 18 15, 16, 18, 19 
18     19.9, CH3 1.30, d (6.3) 17 15, 16, 17 
19 171.62, C
c
 
   
20   105.7, C 
   
21   166.3, C 
   
22   102.7, CH 6.19, d (2.5) 
 
19, 21, 20, 23, 24 
23   163.6, C 
   
24   113.9, CH 6.18, d (2.5) 
 
20, 21, 22, 23, 26 
25   143.7, C 
   
26a     43.6, CH2 3.20, dd (3.8, 13.5) 26b, 27 20, 24, 25, 27, 28 
26b 
 
2.74, dd (9.5, 13.5) 26a, 27 20, 24, 25, 27, 28 
27     72.6, CH 5.14, m 26a, 26b, 28 25, 29 
28     20.6, CH3 1.23, d (6.2) 27 25, 26, 27 
29   172.5, C 
   
30a     45.1, CH2 2.36, dd (6.9, 14.7) 30b, 31 29, 31, 32 
30b 
 
2.26, dd (6.5, 14.7) 30a, 31 29, 31, 32 
31     65.4, CH 4.02, m 30a, 30b, 32 29, 30, 32 
32     23.0, CH3 1.05, d (6.2) 31 30, 31 
a
Signal deduced from the HMBC NMR spectrum. 
b
Signal partially obscured. 
c
Assignments of C-5 and C-19, C-7 and C-9, respectively are interchangeable. 
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Supporting Information for Chapter III 
AIII.1. 
1
H NMR (600 MHz, methanol-d4) spectrum of malettinin E (4). 
 
 
AIII.2. 
13
C NMR (150 MHz, methanol-d4) spectrum of malettinin E (4). 
 
